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CHAPTER 1 
INTRODUCTION 

INTRODUCTION 
Hyperacute antibody-mediated graft rejection: 
Antibodies, Targets, and Kediators 
The fate of transplanted tissues largely depends on the immune 
response of the recipient. This response is generated by 
antigens in the graft, termed transplantation antigens or 
histocompatibility antigens, that are genetically coded for by 
the histocompatibility genes. The most powerful inducers of 
immune defense mechanisms are located as a complex of closely 
related genes on one of the chromosomes, that is called the 
Major Histocompatibility Complex (MHC). The basic structure 
of the MHC of vertebrates of different species shows a 
remarkable homology. At present the best studied MHC regions 
are those of man, called the HLA-complex, located on 
chromosome 6, and those of mice, called the 11-2 complex, which 
is located on chromosome 17. 
The immune response of the host, generated by the 
histocompatibility antigens of the graft, evolves along two 
closely related main systems of defense: The cellular immune 
response, which leads to graft destruction by cytotoxic (τ) 
cells, and the humoral response, in which graft destruction is 
effected by the action of specific antibody, directed against 
the graft tissue and produced by В cells. It has been shown 
that the antigens, coded by separate loci of the MHC, differ 
in the way in which they elicit the immune reaction of the 
host. In this respect two major groups of antigens have been 
distinguished: Class I antigens and Class II antigens. Class 
I antigens have a general tissue distribution and can be 
identified by their capacity to induce antibody formation in a 
non-identical host. These antigens are coded for by the 
HLA-A, B, and С loci of the HLA complex of man and by the H-PK 
and D loci of the H-2 complex of mice. They are also called 
SD (serologically defined) antigens. Class II antigens have a 
restricted cell distribution. They are mainly present on E 
cells, macrophages, monocytes, and activated T-cells, and are 
specifically involved in the induction of proliferative 
cellular immune responses. The ИНС genes that code for the 
class II antigens are located on the HLA-D locus of the HLA 
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complex in man, and in the I region of the H-2 complex in the 
mouse. The Class II antigens of the mouse are also called la 
antigens, i.e. I-region associated antigens, those of man are 
also called DR antigens, i.e. D-region related antigens. 
Early studies on graft rejection were mostly done with skin 
grafts in experimental animals, and they focussed on the 
cellular immune response of the host. The role of antibody, 
formed against the graft tissue was thought to be of minor 
importance (l ,2). Later experiments, however, showed that 
antibodies could play an essential role in the rejection 
process. It was demonstrated that vascularized grafts could 
be hyperacutely rejected when antibodies against the graft 
tissue were circulating in the recipient, and that this type 
of acute graft rejection could be induced by passive transfer 
of serum from a sensitized animal into a non-sensitized 
recipient of the graft (3-5). The interest in the mechanisms 
involved in antibody-mediated graft destruction was further 
stimulated by the occurrence of hyperacute rejection of 
kidneys in clinical transplantation. In this dramatic 
situation the newly transplanted kidney shows blue-red 
discoloration within few minutes after the anastomosis has 
been made between the circulation of host and graft, and the 
kidney has to be removed immediately. Early clinical studies 
on this phenomenon revealed that it was strongly related to 
the presence of antibodies in the circulation of the host, 
directed against tissue antigens of the graft (6,7). 
Moreover, the finding that specific antibodies are also 
involved in chronic forms of rejection, thus accounting for a 
considerable number of graft losses, and that, contrary to the 
cellular immune response, the humoral response of the host is 
not very accessible to immunosuppressive therapy, has further 
increased the interest in the role of antibody in graft 
rejection. 
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factors determining the presence and the expression of the 
targets in the graft, and the role of mediator systems that 
act as effector mechanisms in the induction of the actual cell 
damage after binding of the antibody. 
Part of the experiments, presented in this thesis, have been 
designed to gain a better insight in the mediation systems 
involved in the antibody mediated graft rejection. Since many 
of the conflicting theories in the literature on this subject 
have been based on histological observations, we thought it 
appropriate to use an approach in which not only the 
occurrence of macroscopic graft rejection but also the way in 
which the vasculitis histologically developed could be related 
to manipulations in mediator systems. We have therefore 
started with a description of the morphologic sequence of 
events in its relation to antibody dosage in AAR. 
Subsequently, we have studied the role of two mediator 
systems, viz. the complement system and polymorphonuclear 
granulocytes, that are thought to play an essential role in 
this process. In the last part of this thesis, we concentrate 
on the antigenic determinants of the endothelial cells, and 
especially on the question of whether la antigens can act as 
targets in the graft rejection, that takes place across 
disparities in the I region. 
ARTKUS REACTION and SHWARTZMAH REACTION 
Histologic patterns along which the vasculitis of AAR develops 
are often referred to as resembling an Arthus reaction or a 
generalized Shwartzman reaction (6,8-10). Thus, the terms 
Arthus-like and Shwartzman-like are used to define two 
characteristic and distinct patterns of vasculitis with 
essential differences in the sequence of events. In our 
studies on histologic features and mediator systems in AAR we 
also frequently use the terms Arthus-like and Shwartzman-like 
type of vasculitis, not only as definitions of the morphologic 
events, but also as a basis for discussions on differences in 
the pathogenesis between those types of reaction. Therefore, 
a short overview is given of the main characteristics both in 
morphology and in pathogenesis, of the two corresponding 
experimental models of vasculitis. 
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The Arthus reaction 
The classic Arthus reaction is induced by intradermal 
injection of antigen in an animal that is immune to this 
antigen, i.e. in which antibodies against this antigen are 
circulating (11,12). The macroscopic reaction is a local 
swelling and redness of the skin, proceeding to intradermal 
bleeding and necrosis. In most instances, the maximal 
response is seen between 4 and 10 hr after the injection. 
Histologically, the reaction in the dermis is characterized by 
edema and marked accumulation of polymorphonuclear 
granulocytes (PMNs) in the vessels, visible from 30 min after 
the injection and maximal at 2-4 hr. Subsequently, the PMNs 
infiltrate the vessel walls and the perivascular tissue, and 
vascular damage occurs accompanied by platelet aggregation and 
intravascular coagulation. This is followed by further vessel 
wall destruction, bleeding, and, in severe cases, tissue 
necrosis. The morphologic sequence of events is schematically 
drawn in Fig. 1. Similar local reactions can be evoked when 
antibody is injected intravenously in a non-sensitized animal 
that is subsequently locally injected with antigen (direct 
passive Arthus reaction), by local injection of antibody in 
the skin and intravenous injection of antigen (reversed 
passive Arthus reaction), or by subsequent local injections of 
both antigen and antibody (local passive Arthus reaction) 
(12). The reaction is caused by the binding of antigen and 
antibody, resulting in precipitation of immune complexes 
against the vessel wall. The concomitant activation of the 
complement system leads to formation of chemotactic complement 
components of which especially C5a is a powerful attractant 
for PMNs. Neutrophils accumulate in the vessels and the 
eventual vascular damage is generally thought to be caused by 
the action of lysosomal enzymes released by the granulocytes 
during the process of phagocytosis of the immune complexes. 
Thus, the Arthus reaction is considered to be an immune 
complex vasculitis in which complement and PMNs are essential 
mediators in the induction of vessel wall damage (12). 
Prerequisites for the occurrence of the reaction are that the 
binding of antibody and antigen results in precipitation of 
immune complexes, that the antibodies are capable of 
complement fixation, and that complement and granulocytes are 
available. Elimination of complement from the circulation of 
the animal will prevent the reaction. Also, in the absence of 
neutrophils the reaction will not develop despite demonstrable 
precipitation of antigen, antibody, and complement in the 
vessels (12,13). It is generally accepted that platelets and 
the coagulation system play no essential role in the Arthus 
reaction, since several authors have reported that 
administration of heparin or depletion of platelets does not 
prevent the reaction (12,14,15)· 
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The Shwartzman reaction 
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It should be emphasized that both the Arthus and the 
Shwartzman reaction eventually result in vessel wall 
destruction and tissue necrosis, and that the differences in 
the histologic sequence of events are only clearly apparent in 
the most early stages (Fig. I). 
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Patterns of Vascular Damage in the Antibody-
Mediated Rejection of Skin Xenografts in the Mouse 
M. José J. Th. Bogman, MD, Jo H. M. Berden, MD, 
Jacqueline F. H. M. Hagemann, Cathy N. Maass, and 
Robert A. P. Koene, MD 
Established rat sldn grafts carried by immunosuppressed mice were acutely destroyed by 
an intravenous administration of mouse antirat lymphocyte serum. The histologic pattern 
of destruction was dependent on the amount of antiserum administered. At low doses 
(0.01 ml) an Arthus-like reaction was seen with early accumulation of granulocytes. At 
high doses (0.25 ml) a Shwartzman-like pattern occurred, with early intravascular throm-
bosis and without evident participation of granulocytes in the initial phases. Croups of 
mice that received intermediate doses showed graft changes that were transitional be-
tween these two types of destruction. Similar histologic patterns have been described in 
clinical transplantation. Our results show that they are not fundamentally different and 
that the severity of the triggering reaction determines which of either type will occur. 
(Am J Fatfaol 1980, 100:727-738) 
IN THE FIRST STUDIES of hyperacute rejection of human kidney 
grafts in patients with preexisting humoral antibodies against the major 
histocompatibility antigens of the donor it was found that the renal vessels 
showed extensive intravascular coagulation, suggesting the presence of a 
Shwartzman-like reaction.1"3 
In a subsequent report Myburgh et al * showed that hyperacute rejec-
tion could also occur with histologic changes only consisting of intra-
vascular neutrophil accumulation without fibrin deposition. In these Ar-
thus-like reactions cortical necrosis with fibrin thrombi in the vessels may 
eventually occur, but coagulation is not seen in the initial stages as it is in 
the Shwartzman-like reaction. The relationship between these two types 
of antibody-mediated graft destruction and the factors that determine the 
occurrence of either reaction have not been clarified. 
In an experimental model of hyperacute rejection in the mouse, in 
which established skin allografts carried by immunosuppressed animals 
were acutely destroyed by a single intravenous injection of antiserum, to-
gether with heterologous complement, we found a dense accumulation of 
polymorphonuclear granulocytes in the graft vessels, without deposition 
of fibrin.5 This histologic picture is suggestive of an Arthus reaction and 
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was very similar to the description in the reports of Myburgh et al.4 In a 
comparable model of greater antigenic disparity, in which established rat 
skin grafted to immunosuppressed mice was destroyed by the administra-
tion of mouse antirat serum, the microscopic appearance was also com-
patible with an Arthus reaction. However, at later stages the grafts in this 
model showed extensive intravascular coagulation.8 
So far, Shwartzman-like reactions have not been described in models of 
antibody-mediated skin graft destruction. We assumed that the histologic 
differences of graft destruction in the allogeneic and xenogeneic combina-
tions were related to the antigenic differences between donor and host in 
the two models. A xenograft presents the host with a higher amount of 
foreign antigens than an allograft. It is conceivable that, in a xenogeneic 
combination, the administration of antibodies will lead to a higher con-
centration of antigen-antibody complexes in the graft, resulting in a 
greater generation of secondary destructive mediators, such as com-
plement and chemotactive factors, and thus leading to a more violent his-
tologic reaction. 
We have now used another approach to vary the concentration of anti-
gen-antibody complexes by administering different doses of destructive 
antiserum in the same donor-host combination. In this report we demon-
strate that the patterns of vascular damage that can occur in the acute 
antibody-mediated rejection of xenografts in the mouse are directly re-
lated to the amount of destructive antibody administered. Low amounts 
of antibody gave rise to an Arthus reaction, whereas high amounts caused 
early-occurring intravascular coagulation, resembling a Shwartzman reac-
tion. Intermediate amounts of antibody showed changes that were of a 
transitional type. 
Materials and Methods 
Animals 
Inbred C57BL10 mice were originally obtained from the Jackson Laboratory (Bar Har-
bor, Maine) and inbred PVC/c rats from the Institute of Psychiatry, Bethlem Royal Hospi-
tal, Beckingham (Kent, U.K.). The strains were kept in our laboratory by continuous 
brother-sister matings. 
Antiserums 
Rabbit antimouse lymphocyte serum (RAMLS) was prepared according to the method 
of Gray et al.7 Mouse antirat lymphocyte serum (MARS) was prepared in C57BL10 mice 
by weekly intraperitoneal injections of 5 X 107 PVG/c lymphoid cells suspended in com-
plete Freund's adjuvant. After five injections the animals developed ascites, which was 
tapped weekly. The lymphocytotoxic titer of the ascites fluid was the same as the titer in 
the serum of these mice. The antiserums were pooled and sterilized by passage through a 
sterile 20-mju filter (Schleicher and Schüll, Dassel, West Germany). IgG fractions (RAMLG 
and MARC) of both antiserums were prepared by ammonium sulfate precipitation and af-
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ter dialysis punfied by column chromatography on Sepharose 4B-CL coupled protein A 
The eluates were dialyzed, neutralized, and concentrated to their original cytotoxic titer 
Lymphocytotoxicity of the antiserums was assessed in a trypan blue exclusion assay β The 
titer of MARG was 1 20,480 
Transplantation Procedure 
Male PVG/c tail skin was grafted onto the flank of male C57BL10 recipients by a modi­
fied fitted graft technique β The fate of the graft was followed by daily macroscopic exami­
nation Crafts were considered to be rejected when no viable epithelium remained Me­
dian survival times (MST) and standard deviations (SD) were calculated according to the 
method of Litchfield " To postpone cellular rejection of the grafts, we treated all recipi­
ents with RAMLG on Days —2, —1, 0, 2, and 4 after grafting in a dose of 0 25 ml intra-
pentoneally This immunosuppressive regimen prolonged the median survival time (MST) 
of PVG/c grafts to 23 0 ± 12 days 
Acute Rejection Studies 
On Day 7 after grafting, when all grafts were well healed and showed no signs of rejec­
tion, the recipients received MARG via an intravenous injection in the tail vein Macro­
scopic aspects and histologic features were studied in four groups of mice that had re­
ceived 0 01, 0 05,0 1, and 0 25 ml of MARG, respectively, on Day 7 after transplantation. 
Histologic Examination of the Grafts 
The skin grafts and surrounding recipient skin were removed at different times after the 
intravenous injection of MARG and fixed in 4% buffered formalin From paraffin-embed­
ded tissue blocks 4-μ sections were cut, and they were stained with hematoxylin and eosin 
(H&E), with elastic van Gieson stain for visualization of the vessel walls, with Azan stain 
for accentuation of the graft borders, and with Mallory's phosphotungstic acid-hematoxy-
lin (PTAH) stam to detect fibnn The pathologist (M J В ) who studied the histologic sec­
tions had no prior knowledge of the experimental protocol used The presence of fibrin de­
posits in the Mallory PTAH stain was taken as evidence for the presence of intravascular 
coagulation Platelet aggregation was assumed to be present when homogeneous concen­
trations of platelets were seen in a circular distribution along the vessel walls or obliter­
ating the vascular lumen Polymorphonuclear granulocyte (PMN) accumulation was de­
fined as the presence of polymorphonuclear granulocytes in the vessels in numbers 
exceeding that of erythrocytes and not in evident correlation with platelet aggregation 
Results 
MARG in a dose of 0.1 ml invariably caused macroscopically visible, 
acute graft destruction within 24 to 48 hours after injection, as was shown 
in a preliminary experiment in which 19 recipients of rat skin grafts re­
ceived this dose of antiserum. We then administered the destructive anti­
serum in varying doses to four experimental groups of mice. The effects on 
graft survival as estimated by macroscopic inspection are given in Table 
1. With few exceptions the histologic data were based on observations in 
groups of three mice each. The main histologic findings in four groups of 
similarly treated mice are schematically summarized in Text-figure 1. De­
tails of the histologic examinations are given below. 
In the group that received the lowest dose of antibodies (0.01 ml) the 
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Table 1—Destruction of Rat Skin Grafts by Mouse Anlirat Lymphocyte IgG 
Volume of antiserum 
administered (ml) 
0.01 
0 05 
0.10 
0.25 
— t 
Number of animals 
2 
2 
2 
3 
15 
Day of rejection * 
after transplantation 
2 3 , 3 0 
1 1 , 3 0 
8 , 9 
8 , 8 , 9 
23.0 ± 1 . 2 1 : 
' Grafts were considered to be rejected when no viable epithelium remained. 
f Control animals. 
І Median survival time (MST). 
first reaction consisted of an increase of granulocytes in the graft vessels, 
first present at 30 minutes after the injection and maximal at 2 hours (Fig­
ure 1A and B). This incipient granulocyte accumulation was not accom­
panied by platelet aggregation or intravascular coagulation. Edema and 
vasodilatation were not predominant, and there was no congestion. From 
2 hours after the injection of antiserum there was a progressive accumula­
tion and extravasation of granulocytes (Figure IB and C). Extravasation of 
erythrocytes was first evident at 2 hours and severe at 8 hours. It was al­
ways accompanied by destruction of the endothelium of the vessels. At 8 
hours some of the grafts showed incipient or partial necrosis (Figure 1С). 
Only at 24 hours after injection were there signs of intravascular coagu­
lation, as evidenced by platelet aggregation and the presence of fibrin in 
the FT AH stain (Figure ID). However, these signs were limited to the ne­
crotic areas. Outside these areas no intravascular coagulation or platelet 
aggregation was seen at any stage after the injection of the antiserum in 
this group. 
The grafts that were followed macroscopically showed local signs of ne-
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TEXT-FICURF. 1—Schematic il­
lustration of the histologic find­
ings in the skin grafts after the 
injection of increasing volumes 
of antiserum (MARG). Each 
square represents the observa­
tions in a single mouse. One 
mouse in the group that re­
ceived 0.10 ml antiserum 
showed no reaction 30 minutes 
after injection. 
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Figure 1—Histologic changes after intravenous injection of 0.01 ml MARG. The epidermal surface 
of the graft is oriented to the right. A — 3 0 minutes: increase of polymorphonuclear gran­
ulocytes in the vessels (arrows). (H&E, χ 78) В—2 hours: accumulation of granulocytes in the 
vessels is maximal. (H&E, χ78) С—8 hours: marked extravasation of granulocytes. Partial de­
struction of endothelium and extravasation of erythrocytes. Local necrosis in the graft. No intra­
vascular coagulation is seen. (H&E, χ78) D—24 hours: local necrosis of the graft with intra­
vascular coagulation and platelet-fibrin thrombi only in the area of necrosis (arrows). (PTAH, χ 78) 
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crosis, which seemed to be reversible. Apparently, the amount of anti-
serum given was not sufficient to cause complete rejection of the grafts, 
since ultimate destruction occurred between Day 23 and Day 30, which is 
in the range of the graft survival in control mice. 
In the group of mice that received the highest dose of M ARG (0.25 ml) 
the first reaction was an aggregation of platelets along the vessel walls of 
the graft, which occurred as soon as 30 minutes after the injection (Figure 
2A). This aggregation was accompanied by endothelial swelling and in-
cipient destruction, vasodilatation, hyperemia, and extravasation of 
erythrocytes. These changes had increased 2 hours after injection (Figure 
2B), and at this point local necrosis was already present with an increase 
of granulocytes in the recipient vessels underneath the graft. No accumu-
lation of PMNs was seen in the graft vessels themselves and only a slight 
increase in those vessels in which platelet aggregation was present. At 8 
hours there was clear-cut and total to subtotal endothelial destruction, 
and from this point fibrin threads were visible within the vessels (Figure 
2C). At this stage scattered granulocytes were found in the vessels only in 
those areas where platelet aggregation or intravascular coagulation was 
also present. Microscopically the grafts showed total to subtotal necrosis 
after 24 hours (Figure 2D). Table 1 shows that, with this dose of antibody, 
macroscopic rejection was completed 24-48 hours after the injection. 
The group of mice that received 0.10 ml of MARG showed a reaction 
pattern that was in broad outline similar to that of the group that received 
the highest dose, with the exceptions that in this group platelet aggrega-
tion at 30 minutes was somewhat less and that the first necrosis was seen 
not after 2 hours but after 8 hours. 
Otherwise the histologic picture was identical. 
In the group of mice that received 0.05 ml of antiserum one of the 
grafts showed, at 30 minutes after injection, a slight increase of PMNs in 
the graft vessels. At 2 hours 1 of 3 mice showed PMN accumulation in the 
vessels in one part of the graft and platelet aggregation in another. The 
two other mice of this group showed at this moment platelet aggregation 
without conspicuous PMN accumulation. Scattered PMNs were only seen 
in relation to platelet aggregation and were considered to be reactive to 
this aggregation. At 8 hours after injection considerable platelet aggrega-
tion could be observed, together with the presence of fibrin in the vessels 
and the occurrence of partial necrosis. At 24 hours these phenomena were 
more severe, 1 of the mice showing complete necrosis of the graft. From 
the 2 mice that were followed macroscopically in this group 1 showed hy-
peracute rejection of the graft at Day 11, while the other graft was not 
affected by the MARG injection (Table 1). 
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Figure 2—Histologie changes affer intravenous injection of 0.25 ml MARG. A—30 minufes: in­
cipient accumulation of thrombocytes along the vessel walls and vasodilatation (arrows). Erythro­
cytes are black; platelets are gray. (Azan, χ78) В—2 hours: accumulation of thrombocytes 
has increased; thrombi are partly occluding the vascular lumens (arrows). (Azan, χ 78) С—8 
hours: accumulation of thrombocytes along the vessel wall with deposition of fibrillar material (ar­
row). Granulocytes are not present in increased numbers. (H&E, χ 125) D—24 hours: subtotal 
necrosis of the graft with destruction of vessel walls. Obstruction of the graft vessels by platelet fi­
brin thrombi (arrows). (PTAH, χ78) 
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Discussion 
Our results confirm the clinical observations 3 ·4 that in acute, antibody-
mediated graft rejection both Arthus-like and Shwartzman-like reactions 
can be present. They shed some light on the factors that determine which 
type of histologic pattern will occur. A relationship between both types of 
reaction is strongly suggested by our finding that it is possible to induce a 
transition from one type of reaction into the other by simply increasing 
the amount of destructive antibody. The differences between the reac-
tions were most clearly seen in the histologic sections of the early phases 
of graft rejection. At the terminal stages, when necrosis of the graft had 
occurred, the reactions became almost indistinguishable. This finding is in 
accordance with previous reports, that, in considering the similarities and 
differences of the classic Arthus and Shwartzman reactions, study of the 
early phases is essential to evaluate the results.1011 Our model, in which 
low doses of antiserum were administered, can be considered as a direct 
passive variant of the Arthus reaction. The antigens against which the de-
structive antibodies are directed are present at the graft site, and most 
likely the histocompatibility antigens on the endothelial cell membrane 
are the primary target for the antibody. Binding of the antibody sets going 
a chain of events that via complement activation and PMN attraction 
leads to endothelial damage 1 0 ·1 2 and, if the reaction is severe enough, to 
intravascular coagulation. Morphologically the early accumulation of 
PMNs is the most salient feature. The findings in the group of mice that 
received the lowest dose show that such an accumulation does not neces-
sarily lead to coagulation and necrosis. Some grafts escaped from destruc-
tion or showed only patchy necrotic changes. 
In the two groups of mice that received the highest doses of antiserum 
(0.10 and 0.25 ml) there was acute thrombosis in the graft vessels without 
an increase of PMNs in the early phases of the reaction. A mild increase of 
PMNs in the vessels did occur during the process of thrombosis, but before 
this was seen there was already an abundant accumulation of platelets. It 
is likely that the PMNs were attracted secondarily by chemotactic factors, 
released during the clotting process.13 In the generalized Shwartzman re-
action, which is classically provoked by two separate injections of endo-
toxins, there is also an acute intravascular coagulation in which PMNs are 
absent from the thrombi " or present only in very few numbers.15 Al-
though these alterations closely resemble the histologic pattern found in 
our experiments with the high doses of antiserum, the mechanism of tissue 
damage is probably not the same. The generalized Shwartzman reaction is 
probably initiated by a direct activation of the coagulation process.15 The 
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thrombi seem to consist mainly of fibrin without many platelets.1 5 1 7 The 
hyperacute rejection in the mice receiving the high doses of antibody is 
clearly initiated by endothelial damage with consequent platelet aggrega­
tion and thrombosis (Figure 2A-C). This reaction is also different from the so-
called local Shwartzman reaction, in which the preparative dose of the in­
citing agent is given intradermally.1'' In this reaction PMNs are abun­
dantly present in the tissue before the second, provoking injection is 
given.16 The presence of PMNs seems to be even essential here, since 
granulocyte depletion with nitrogen mustard will prevent the reaction.16 
Furthermore, in the local Shwartzman reaction PMNs form a conspicuous 
part of the thrombi. 1 4 1 5 1 7 Whether PMNs are necessary for the general­
ized Shwartzman reaction is a matter of debate. 1 5 Ι β · 1 9 
Because of these differences between the antibody-mediated graft rejec­
tion and the classic Shwartzman reaction, it seems a simplification to clas­
sify them in the same category. I t is therefore more approriate to describe 
the graft rejection in terms of the mechanism involved and to try to ex­
plain the different patterns on this basis. The following description seems 
to accommodate both types of reaction, and the hypothesis on which it is 
based can be tested experimentally. 
Small amounts of antibody fixed to antigen on the vessel wall will cause 
only little endothelial damage. Consequent complement activation with 
generation of chemotactic factors will attract PMNs.20 These will phago­
cytose immune complexes21 and release injurious constituents,22 which 
will cause further damage to the endothelium.17,21"23 The damaged cells in 
their turn attract more PMNs ** and thus further enhancement of the re­
action can occur. As soon as destruction of endothelium and disruption of 
the basement membrane or lamina elastica interna of the vessels occur, 
exposure of the thrombogenic 2 5 , 2 e subendothelial tissue takes place. When 
larger amounts of antibodies are injected, endothelial cells may become 
completely destroyed by a direct cytolytic action of antibody and com­
plement, implying that the thrombogenic subendothelial tissues will be­
come immediately exposed to the blood flow, without intervention of 
PMNs, and rapid thrombosis will already have begun before chemotactic 
factors can become operative. Since the two reactions are based on the 
same inciting mechanism, one may expect that they can occur together in 
the same graft. This is exactly what we found in the grafts of animals that 
received intermediate doses of antiserum. 
This interpretation of our results implies that in the group that received 
the high dose procedures to prevent coagulation or platelet accumulation 
will make the grafts accessible to PMNs and will thus change the Shwartz-
man-like pattern into an Arthus-like pattern. On the other hand, severe 
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depletion of PMNs will not prevent graft destruction, provided the dose 
of antiserum is so high that it can cause immediate intravascular coagu­
lation. There are indications that this latter phenomenon indeed can oc­
cur. Cochrane has reported that in experiments designed to prevent a 
classic Arthus reaction by PMN depletion, the amount of antibody admin­
istered should not exceed certain levels. Otherwise a severe intravascular 
coagulation can occur.12 
Our experimental model of graft destruction by different doses of anti­
serum provides a relatively simple tool with which one can study the in­
volvement of the different factors mentioned. It can thus contribute to a 
better understanding of the mechanisms of vascular damage in the rejec­
tion process. 
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Rat skin grafts carried by immunosuppressed mice can 
be acutely destroyed by intravenous administration of 
mouse anti-rat antibody. The velocity of the reaction 
and the histologic sequence of events depend on the 
amount of antibody administered: low doses give an 
Arthus-like rejection, whereas at high doses a Shwartz-
man-like pattern occurs. Depletion of СЭ by cobra 
venom factor treatment did not prevent acute rejection 
after intravenous injection of high doses of antiserum 
but changed the reaction from a Shwartzman-like to an 
Arthus-like pattern. Conversely, supplementary ad­
ministration of rabbit complement caused a violent 
Shwartzman-like graft destruction after injection of 
low doses of antibody, which in complement-normal 
mice gave an Arthus-like reaction. The results show 
that complement can greatly amplify the antibody-
mediated immune vasculitis and can substantially mod­
ify its histologic pattern. It is, however, not an absolute 
requirement for the occurrence of the destructive pro­
cess. (Am J Pathol 1982, 109:97-106) 
THE IMPORTANT ROLE of complement as an am­
plification system in acute antibody-mediated graft 
rejection (AAR) has been repeatedly demonstrated, 
both in clinical kidney transplantation' and in experi­
mental allografts2"5 and xenografts." ' In two experi­
mental systems, in which AAR was induced by the 
administration of specific antibodies to immunosup­
pressed mice carrying skin allografts or xenografts, 
the participation of complement in the rejection 
process was extensively studied.4 * ' In the allograft 
system the weakly acting endogenous complement of 
the mouse appeared to be insufficient to provoke 
hyperacute rejection after the administration of high 
doses of alloamibody specifically directed against the 
graft antigens. Concomitant administration of heter­
ologous complement from rabbit, guinea pig, or hu­
man origin was necessary to induce acute graft de­
struction.1 However, if mice were grafted with rat 
skin, which obviously represents a larger antigenic 
difference, the endogenous complement system proved 
to be sufficient to induce acute destruction after the 
administration of anti-rat antibody. In this model it 
has been shown that AAR could be induced in 
C5-deficient mice but less easily in mice treated with 
cobra venom factor (COVF), suggesting that espe­
cially activation of C3 was necessary for the amplifi­
cation of the inflammatory reaction.' These findings 
suggested that complement fixation was essential for 
hyperacute rejection to occur, but a recent study has 
raised doubts about the general validity of this as­
sumption. Experiments of Berden et al7 showed that 
acute antibody-mediated destruction of skin xeno­
grafts can be induced both in C3-depleted and in 
C5-deficient mice, or, alternatively, with non-com­
plement-fixing antibody, provided that the dose of 
antibody is sufficiently raised. 
Insight into the role of complement, its mode of 
action, and the subsequent histologic events is not 
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only important for our understanding of the mecha­
nisms that lead to antibody-mediated graft rejection, 
but may also give information about closely related 
processes based on immunologic injury of blood ves­
sels, such as serum-sickness, autoimmune or allergic 
vasculitis, and glomerulonephritis. Together with 
similarities in pathogenesis, these processes share his­
tologic features that have been compared with those 
of experimental Arthus and Shwartzman reactions.9"10 
The morphologic resemblance of acute antibody-
mediated rejection to Arthus and Shwartzman reac­
tions has been described both in human kidney allo­
graft rejection11"" and in experimental allografts2 " lé 
and xenografts.'17 We showed in a previous report 
that acute antibody-mediated rejection of rat skin 
xenografts in mice can develop either along an 
Arthus-like pattern, characterized by early accumula-
tion of polymorphonuclear granulocytes (PMNs) in 
the graft vessels, subsequent intravascular coagula-
tion, and eventual necrosis, or along a Shwartzman-
like pattern characterized by early intravascular 
coagulation.1' Which of these patterns would devel-
op was solely dependent upon the amount of anti-
body injected, high doses giving the more violent 
Shwartzman-like rejection, low doses causing a more 
slowly developing Arthus-like reaction, which never-
theless also led to total necrosis of the graft within 72 
hours in about 50% of the animals. We assumed that 
the intensity of the reaction in the graft vessels was 
directly related to the number of antigen-antibody 
complexes in the graft. If the amount of fixed anti-
body is sufficient to cause immediate and complete 
destruction of the vascular endothelium, the subse-
quent exposure of the subendothelial tissues will 
cause early intravascular coagulation, consistent with 
a Schwartzman-like reaction. If the amount of anti-
body only causes partial endothelial damage, the ulti-
mate necrosis will be brought about by destruc-
tive mediators, ie, PMNs, attracted by chemotactic 
factors, thus generating an Arthus-like pattern of 
rejection. 
If our conclusion is right that the histologic pattern 
along which the acute antibody-mediated graft rejec-
tion develops is directly related to the destructive 
power of the first attack of antibody on the endothe-
lial cells, it is to be expected that variations in the 
availability of complement, as one of the main medi-
ators of the damaging process, can cause the same 
drfierences in reaction patterns to certain doses of an-
tibody. In this report we demonstrate that C3 deple-
tion by COVF treatment of immunosuppressed mice, 
carrying established rat skin grafts, could not prevent 
the acute rejection induced by intravenous adminis-
tration of high doses of antibody but changed its pat-
tern from a Shwartzman-like reaction to an Arthus-
like one. Conversely, the supplementary administra-
tion of rabbit complement, together with the injection 
of low doses of antibody, could considerably enhance 
the effect of these low doses and change an Arthus-like 
pattern of acute rejection into a Schwartzman-like 
one. 
Materials and Methods 
Animals 
Inbred strains of C57B1/10 mice were originally 
obtained from the Jackson Laboratory (Bar Harbor, 
Maine) and inbred PVG/c rats from the Institute of 
Psychiatry, Bethlem Royal Hospital, Beckingham 
(Kent, U.K.). In our laboratory these strains were 
kept by continuous brother-sister matings. Goats, used 
to prepare anti-lymphocyte serum, were bought on 
the local market. The serum of New Zealand white 
rabbits was used as a source of complement. 
Antiserums 
Mouse anti-rat lymphocyte serum (MARS) was 
prepared in C57B1/10 mice by weekly intraperitoneal 
•injections of 5 χ 10' PVG/c lymphoid cells suspended 
in complete Freund's adjuvant (CFA). After five in­
jections the animals developed ascites, tapped weekly. 
The lymphocytotoxic titer of the ascites fluid, as de­
termined in a trypan blue exclusion assay, was the 
same as the titer in the serum of these mice. We 
pooled and heated the antiserums at 56 С for 45 min­
utes to destroy complement activity, and sterilized 
them by passage through a sterile 20-Γημ filter 
(Schleicher and Schuil, Dassel, Western Germany). 
The IgG fraction of the antiserum (MARG) was pre­
pared by ammonium sulfate precipitation and, after 
dialysis, purified by column chromatography on 
Sepharose-4B-CL-coupled protein A. The eluates 
were dialyzed, neutralized, and concentrated to their 
original cytotoxic titer. Lymphocytotoxicity of the 
antiserum was assessed in a trypan blue exclusion 
assay. The cytotoxic titer of the MARG was 
1: 16,000. 
Goat anti-mouse lymphocyte serum (GAMLS) was 
prepared by a subcutaneous injection of 10" C57B1/10 
lymphocytes in CFA into a goat, followed by weekly 
intravenous boosts of the same number of C57B1/10 
lymphoid cells. The serum obtained 1 week after the 
fifth immunization was heated at 56 С for 45 min­
utes, and, after precipitation with ammonium sul­
fate, dialysis, concentration to the original volume, 
and sterilization, stored at -20 С. 
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Transplantatton Procedure 
Squares of 0 8 χ 0 8-cm full-thickness skin from 
male PVG/c tails were grafted onto the flanks of 
male C57B1/10 recipients by a modified fitted graft 
technique 4 The fate of the grafts was followed by 
daily macroscopic examination Grafts were con­
sidered to be rejected when no viable epithelium re­
mained Median survival times (MST) and standard 
errors were calculated according to the method of 
Litchfield " To postpone cellular rejection of the 
grafts, we treated all recipients with GAMLS on 
Days - 2 , - 1, 0, 2, and 4 after grafting in a dose of 
0 25 ml intrapentoneally This immunosuppressive 
regimen prolonged the MST of the PVG/c skin grafts 
to 27 0 ± 1 1 days 
Acute Rejection Studies 
On Day 7 after grafting, when all grafts were in ex­
cellent condition and showed no signs of rejection, 
the recipients received MARC via an intravenous in­
jection into the tail vein Macroscopic aspects and 
histologic features of the resulting graft destruction 
were then studied AAR was defined as the complete 
necrosis of the graft within 24-72 hours after the in 
travenous injection of MARG 
Complément Depletion 
Complement depletion was induced by COVF, 100 
U/ml (Cordis Ltd, Miami, Fla ) This preparation 
was administered from Day 5 until Day 9 after trans-
plantation in daily intraperitoneal injections of 20 U 
We have previously shown that this dose regimen 
lowers the serum complement activity to unmeasur-
able levels from 24 hours after the first injection ' On 
Day 7 after transplantation the intraperitoneal injec-
tion of COVF was given 2 hours before the intra-
venous injection of MARG 
Complement Suppletion 
Fresh frozen serums from rabbits, stored at - 70 C, 
were used as a source of complement (RC) To make 
certain that the rabbit serum was not a source of anti-
body activity against the rat xenograft, we absorbed 
it with PVG/c lymphoid cells One ml of packed cells 
was incubated with 5 ml RC during 10 minutes at 4 С 
Both before and after this incubation, no cytotoxic 
activity of the RC against PVG/c cells could be de­
tected in the trypan blue exclusion assay In the mice 
that received complement suppletion, the RC was in­
jected intravenously, together with the antibody, in a 
dose of 0 25 ml In control experiments absorbed RC 
was used after heat inactivation at 56 С for 45 
minutes 
Histologic Examination of the Grafts 
The skin grafts and surrounding recipient skin 
were removed at different times after the intravenous 
injection of MARG and fixed in 4% buffered for-
-malin From paraffin-embedded tissue blocks 4 μ sec­
tions were cut and stained with hematoxylin and 
eosin (H&E), Giemsa, Azan, elastic van Gieson stain, 
and Mallory's phosphotungstic acid hematoxylin 
(PTAH) stain for detection of fibrin The presence of 
fibrin deposits in the Mallory PTAH stain was taken 
as evidence for the presence of intravascular coagula­
tion Platelet aggregation was assumed to be present 
when homogeneous concentrations of platelets were 
seen in a circular distribution along the vessel walls or 
obliterating the vascular lumen Polymorphonuclear 
granulocyte (PMN) accumulation was defined as the 
presence of PMNs in the vessels in numbers exceed­
ing that of erythrocytes and not in evident correlation 
with platelet aggregation The histologic descriptions 
were based on findings in at least 3 mice per observa­
tion point 
Results 
Influence of COVF Treatment on the Histologic 
Features of Acute Antibody Mediated Rejection 
Table 1 shows the dose-response relationships of 
the MARG injections in normal and in complement-
depleted recipients In immunosuppressed mice that 
had a normal complement status, injection of 0 005 
ml MARG on Day 7 after transplantation caused a 
transient edema in the grafts, visible between 2 and 8 
hours after injection, but did not lead to acute rejec­
tion of any of the grafts (Group 2) The MST of these 
grafts was 26 9 ± I I days and was not significantly 
different from the MST of 27 0 days in the control 
group that received no antibody (Group 1) A dose of 
0 01 ml MARG caused total necrosis in about 50% of 
the grafts within 72 hours after injection (Group 3) 
The remaining grafts of this group showed, after an 
initial stage of edema and redness, either a slowly de­
veloping deterioration of condition or complete re­
covery, leading to a MST of 13 5 ± 14 days for the 
group as a whole The histologic sequence of events 
in the grafts of this group was the same as described 
in detail in an earlier report " Briefly, the acute vas­
culitis that led to necrosis of the graft after injection 
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Table 1 - Influence of COVF Trealmenl on the AAR of 
PVG/c Skin Grafted Onto Immunosuppressed С57ВІИ0 
Recipients 
Group 
number 
1 
2 
3 
4 
5 
6 
7 
В 
9 
10 
11 
12 
13 
Dose 
of 
MARG* 
_ 
0005 
001 
005 
010 
025 
_ 0.01 
010 
0 25 
050 
1.00 
2.00 
COVFt 
treat­
ment 
_ 
-
-
-
-
-
+ 
+ 
+ 
+ 
+ 
+ 
+ 
AAR* 
0/12 
OS 
a/19 
4/5 
9/9 
10/10 
cm 
0/8 
0/8 
6/11 
14/14 
a/8 
a/8 
Histologic features 
of AAR§ 
_| 
-Arthuslike 
Arthus-Shwartzrnan-hkel 
Shwarlzman-like 
Shwaruman-llke 
-
-
-Arthus-llke 
Anhus-llke 
Arthuslike 
Arthuslike 
* MARG was Injected intravenously on Day 7 after grafting. 
t Twenty units o( COVF was Injected Intraperltoneally daily, start­
ing on Day 5 after grafting, and was continued tor 5 days or until re­
jection was complete 
t Number of mice with complete necrosis of the graft within 24-72 
hours after MARG Injection per number of mice tested 
S Histologic observations made at 30 minutes, 2 hours, 8 hours 
and 24 hours after MARG injection m groups of 3 mice per point. 
I Median survival time 27 0 ± 11 days 
1 Both types of vasculitis In the same graft 
of a dose of 0.01 ml MARG was characterized by ear­
ly intravascular accumulation of polymorphonuclear 
granulocytes in the vessels, first seen at 30 minutes 
after injection and maximal at 2 hours. In later 
stages, from 8 hours after injection there was increas­
ing vessel wall damage and intravascular coagulation 
leading to partial necrosis of the graft at 24 hours. 
This type of vasculitis strongly resembles that of an 
Arthus reaction. Intravenous injection of doses of 
0.10 and 0.25 ml of MARG provoked a more violent 
reaction in the grafts, with swelling, cyanosis, and 
bleeding, from 2 hours after injection, and increasing 
necrosis in all grafts, until no viable epithelium re­
mained after 24-48 hours (Groups 5 and 6). 
Histologically, these grafts showed an acute vascu­
litis that was characterized by early platelet aggrega­
tion along the vessel walls, first visible at 30 minutes 
and extensive at 2 hours. From this time in­
travascular coagulation was seen, with severe damage 
of the vessel walls and extensive bleeding. From 8 
hours necrosis was prominent, and rejection invari­
ably followed. The sequence of events of in this type 
of vasculitis closely resembles that of an experimental 
Shwartzman reaction. As we have mentioned in our 
previous report," the difference between the Arthus­
like and Shwartzman-like types of vasculitis can best 
be seen in the early stages of the process, since in the 
later phases intravascular coagulation and necrosis 
occur in both types. 
When we compared the reaction of the grafts to 
similar doses of MARG in complement-normal recip­
ients with those in the COVF-treated groups, we found 
that in the complement-depleted animals the sensitiv­
ity to MARG was markedly decreased (Groups 8-
13). However, all grafts could again be destroyed by 
the raising of the dose of antibody to 0.50 ml. These 
results show that acute graft destruction can be in­
duced in recipients that have no measurable amounts 
of serum complement activity and confirm the find­
ings of our previous study.' To study the influences 
of complement depletion on the histologic sequence 
of events during the acute graft rejection, we com­
pared the histologic reactions to a dose of 0.25 ml of 
antibody in complement-normal mice with those in 
mice treated with COVF. In the complement-normal 
mice the grafts showed early platelet aggregation along 
the vessel walls, already visible 30 minutes after injec­
tion, accompanied by vasodilatation, hyperemia, in­
cipient endothelial destruction, and extravasation of 
erythrocytes. Two hours after injection these changes 
had markedly increased. There was severe endothelial 
destruction, and intravascular fibrin threads were 
demonstrable with the Mallory stain (Figure 1A). 
At 24 hours the grafts showed total to subtotal 
necrosis. PMNs did not play an essential role in this 
process of rejection at any moment. In the first 2 
hours after injection of the antiserum no accumula­
tion of PMNs was seen in the graft vessels, except for 
a slight increase in those areas wherein platelet aggre­
gation was already evident. Also at 8 hours PMNs 
were only present in small numbers in areas of intra­
vascular coagulation, platelet aggregation, and 
necrosis. 
In the groups that were depleted of complement by 
administration of COVF, the histologic sequence of 
events was different. In these mice the first reaction 
after injection of the same dose of antiserum (0.25 
ml) consisted of a considerable increase of PMNs in 
the graft vessels, first seen at 30 minutes, and maxi­
mal at 2 hours (Figure IB). At these stages no platelet 
aggregation or intravascular coagulation could be 
found, and the grafts showed only minimal edema 
and congestion. The endothelium of the graft vessels 
generally showed a moderate swelling of the cells, but 
no signs of destruction. At 8 hours platelet aggrega­
tion and intravascular coagulation were evident, to­
gether with vessel wall destruction and marked extra­
vasation of erythrocytes. At this time the grafts 
showed partial necrosis, varying between 10% to 
30%. After 24 hours the histologic changes were not 
essentially different from those after 8 hours, but the 
degree of necrosis varied between 10% and 90%. 
Macroscopic rejection occurred in 6 of 11 animals 
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Figure 1-Influence of complement 
depletion on the histologic pattern 
of vessel wall damage in AAR. 
A-Pattern In complement normal 
mice at 2 hours after injection of 
0 25 ml MARG Extensive platelet 
aggregation along the vessel walls 
(arrows), in which there are locally 
visible fibrin threads (arrowheads) 
Destruction of endothelial cells, con­
gestion, and extravasation of eryth­
rocytes (black) (Mallory's PTAH, χ 78) 
В - Pattern m COVF-treated nuce at 
2 hours after the same dose of 0 25 
ml MARG Intensive accumulation 
of PMNs in the vessels No endothe 
liai cell lysis and no intravascular 
coagulation at this stage H, hair 
follicle of the graft. (H&E, χ 125) 
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(Table 1, Group 10) and this rejection developed 
more slowly than that in the complement-normal 
group. Partial recoveries were also seen. In the 
COVF-treated mice the number of PMNs in the ves­
sels at 2 hours after injection of MARG was in gener­
al higher than that seen in the Arthus-like reaction of 
complement-normal mice after low doses of antibody 
(Figure IB and Figure 2A). This result is probably 
related to the higher numbers of circulating PMNs in 
COVF-treated animals (Table 2). Attempts were 
made to induce a Shwartzman-like response in 
COVF-treated mice by a further increase in the 
amount of injected antibody, but even doses as high 
as 2.0 ml MARG (given as 0.50 ml of four times con­
centrated serum) still resulted in an Arthus-like type 
of reaction. (Table 1, Groups 11-13). Control mice 
that received CO VF alone without MARG (Table 1, 
Group 7) showed no macroscopic reaction in the 
grafts and had a MST similar to that of Control 
Group 1. Microscopically these COVF-treated mice 
showed on Day 7 after grafting only a minimal in­
crease of PMNs in the vessels, consistent with the 
general increase in circulating PMNs after COVF 
treatment. 
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Figure 2-Influence of complement 
suppletion on the histologic pattern 
of vessel wall damage in AAR. 
A-Pattern in complement-normal 
mice at 2 hours after injection of 
0008 ml MARG Accumulation of 
PMNs m the vessels No endothelial 
cell lysis and no intravascular coag-
ulation at this point F, fat vacuole 
(H&E, X125) B-Pattern at 2 
hours after injection of 0 25 ml RC 
together with 0 008 ml MARG De-
struction of endothelial cells, plate-
let aggregation along the vessel 
wall (arrowsi, and extravasation of 
erythrocytes- H, hair follicle of the 
graft (H&E, x160) 
Influence of Complement Suppletion on AAR 
The finding that complement depletion diminished 
the destructive effect of antibody on the grafts sug-
gested the possibility that suppletion of exogenous 
complement could enhance the destructive effect of 
subliminal doses of antibody. In our system the limit-
ing dose of MARG that could cause acute antibody-
mediated rejection in about 5(Wo of complement-
normal mice was 0.01 ml (Table 1, Group 3). We 
therefore tested the effectiveness of this and two 
lower doses of MARG, (0.01, 0.008, and 0.005 ml, 
respectively) when a simultaneous injection of 0.25 
ml of RC was given intravenously. Control groups 
received MARG with heat-inactivated RC or fresh 
RC alone. The effect on graft survival with and with-
out RC is shown in Table 3. Simultaneous injection 
of 0.25 ml RC enhanced the effect of 0.01 ml MARG 
from a rather slowly developing rejection in four of 
five grafts within 72 hours to a rapid graft destruction 
in all animals within 48 hours (Group 1). Injection of 
0.008 ml MARG with and without RC gave compar-
able results. A dose of 0.005 ml MARG that normal-
ly induced no significant decrease of graft survival 
(Table 1, Group 2, MST 26.9 ±1 .1 days) also caused 
after simultaneous injection of 0.25 ml RC, AAR in 
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Table 2 - T h e Influence of COVF Treatment on the Number 
of Peripheral Granulocytes m Male C57BI/10 Mice 
COVF 
treatment* PMN/cu mmt 
Untreated - 880 ± 61 
+ 3402 ι 432 
Immunosuppressed mice carrying - Θ7Β ± 222 
rat skin grafts + 3667 ± 686 
' Dally intraperitoneal Injections of 20 U COVF were given during 
3 days, and PMNs were counted 2 hours alter the third Injection In 
the transplanted group COVF-treatment was started at Day 5 after 
grafting. 
t Mean values of 4 mice ± SEM. 
1004ο of animals within 72 hours (Table 3, Group 3). 
The macroscopic experiments were repeated twice, 
and the results were completely reproducible. 
For histologic examination of all three groups and 
control groups, grafts were removed at 2 hours after 
the injection of the antiserum. As pointed out before, 
this is the best moment for determination of the type 
of vasculitis in progress, especially whether it is 
Arthus-like or Shwartzman-like. The grafts of mice 
that received 0.01 ml MARG without RC showed a 
rejection pattern that at 2 hours was characterized by 
intravascular accumulation of PMNs with only very 
sporadic and slight platelet aggregation. Even this 
minimal platelet aggregation was absent in the group 
that received 0.008 ml of MARG without RC, and 
here we saw a pure Arthus-like reaction, with intra­
vascular accumulation of PMNs, but without vessel 
wall destruction and with only minimal edema (Fig­
ure 2A). In the mice that received 0.005 ml MARG 
without RC the grafts showed some edema and a 
moderate increase of PMNs in the vessels, but these 
changes had no substantial effect on the ultimate graft 
survival. In contrast with these findings, the grafts of 
the mice that had received RC with 0.01 and 0.008 ml 
MARG all showed at 2 hours extensive intravascular 
platelet aggregation, endothelial damage, edema, 
massive extravasation of erythrocytes, and incipient 
necrosis, ie, a typical Shwartzman-like reaction (Fig­
ure 2B). The reaction in the group that received 0.005 
ml MARG with RC was somewhat less severe, mac-
roscopically and histologically, but nevertheless also 
of the Shwartzman type, with evident platelet aggre­
gation and vessel wall damage at 2 hours. Without 
the addition of RC, a rapid Schwartzman-like reaction 
is only seen after intravenous injection of doses of at 
least 0.10 ml MARG (Table 1, Group 5). Thus, ad­
ministration of RC together with low and subliminal 
doses of MARG not only increased the destructive ef­
fect of the antiserum with a factor greater than 20, but 
it also changed the histologic sequence of events from 
an Arthus-like pattern of rejection, in which medi­
ation of PMNs seems essential, to a Shwartzman-like 
pattern, caused by immediate endothelial destruction. 
Discussion 
Clinical and experimental studies have shown that 
the histologic patterns of the acute antibody-mediated 
graft rejection closely resemble those seen in other 
types of immune complex injury2"7 "'" and that 
complement and PMNs can play an important role as 
secondary mediators. It is therefore not surprising 
that attempts have been made to prevent destruction 
by elimination of these mediators. With regard to the 
effect of complement depletion, these studies have 
given contradictory results.'7 Our study might ex­
plain these apparent contradictions because it shows 
that the effects of complement are only interpretable 
if there is insight into the amount of antibody avail­
able for binding to the corresponding antigen. When 
the amount of antibody injected is limited, and only 
sufficient to cause little or moderate damage to the 
graft, the destructive effect can be greatly enhanced 
by addition of an efficient complement source to the 
system (Table 3). However, at high doses of antibody 
the role of complement becomes minor or even com­
pletely superfluous, since AAR can then be induced 
in COVF-treated recipients that have no detectable 
complement activity. It is obvious that the concentra­
tion of antigen, ie, the degree of antigenic difference 
ТаЬІеЗ-Influence of Simultaneous Intravenous 
Administration ol 0.25 ml RC Together with 
Liminal and Subliminal Doses of MARG on 
the AAR of PVG/c Skin Grafted Onto 
Immunosuppressed C57BI/10 Recipients 
Dose 
'MARG 
(ml)' 
0 01 
001 
0008 
0008 
0 005 
0 005 
-
RCt 
+ 
+ 
+ 
+ 
AAR* 
4/5 
5/5 
2/4 
4/4 
0/5 
4/4 
0/5 
Histologic 
features of 
AAR§ 
Arthushke' 
Shwartzman like 
Arthus-like 
Shwartzman-like 
_ 1 
Shwartzman-like 
-
* MARG was injected on Day 7 after grafting 
t The RC was absorbed with PVG/c lymphoid cells (see Methods) 
The control groups received the same absorbed RC after heat mactl-
vation ( - ) 
t Number of mice with complete graft necrosis within 24-72 hours 
after MARG Injection per number of mtce tested 
§ Histologic features of AAR as seen at 2 hours after injection of 
MARG m three grafts per group 
I In two of the grafts there was sporadic platelet aggregation 
1 Transient edema and increase of PMNs in the vessels, nol signif­
icantly affecting the ultimate graft survival 
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between graft and host, is important as a third factor 
that determines the sensitivity of the graft to destruc­
tion by antibody This factor is not a limiting one in 
the model that we have used here, because the xeno­
geneic difference makes it likely that antigenic targets 
are available in excess However, in allogeneic 
models, in which the genetic difference is much 
smaller, antigen can become the limiting factor This 
is clearly illustrated by our previous finding that 
AAR in allografts cannot be induced by antibody 
alone, even when high doses are injected In these 
models the addition of an efficient heterologous com­
plement, together with the antibody, is necessary for 
one to obtain sufficient damage to the vessel walls for 
AAR to occur 2" s The fact that in the xenogeneic 
model AAR can be induced without the addition of 
heterologous complement has made this model suit­
able for the study of the role of complement, ie, the 
study of the effect of complement depletion on the one 
hand and of complement suppletion on the other 
Histologically, AAR, as a type of immunologically 
mediated vasculitis, can develop either as a Shwartz-
man-like or as an Arthus-like reaction In a previous 
study we showed that the histologic pattern can be al­
tered from an Arthus-hke into a Shwartzman like re­
action by a simple increase in the amount of admin 
istered antibody " The results of the current study 
demonstrate that addition of an efficient heterologous 
complement can have a similar effect (Table 3, Groups 
1 and 2) It enhances the destructive power of low 
doses of antibody to such extent that immediate en­
dothelial cell lysis will occur At that moment the ex­
posure of subendothelial tissues to the blood flow will 
cause early platelet aggregation, without mediation 
of PMNs, and rapid necrosis of the graft will take 
place along a Shwartzman-hke pattern If no heterol­
ogous complement is added to the system the reac­
tion will be dependent on the antibody in cooperation 
with the much less efficient mouse complement The 
total destructive power will then be insufficient to 
cause immediate lysis of the endothelial cells, but 
chemotactic factors released by the immune reactants 
and by the moderately damaged cells will attract 
PMNs, which subsequently, by release of their lyso­
somal enzymes, act as mediators in the amplification 
of the destructive process Thus, the intravascular se­
quence of events will be similar to that of an Arthus 
reaction These findings bring Arthus-like and 
Shwartzman-hke types of acute rejection together 
into one spectrum of antibody-mediated vasculitis 
They suggest that apparent controversies in the litera­
ture about the pathogenesis and histologic features of 
immune vasculitis can be related to differences in 
concentrations of immune reactants or secondary 
mediators in the respective experimental systems 
A point of interest in our study is that in the Shwartz­
man-hke pattern that follows the injection of high 
doses of MARG or the injection of low doses of 
MARC combined with rabbit complement, the medi­
ation of PMNs is apparently not essential for endo­
thelial destruction, because PMNs are not seen m in­
creased numbers in the vessels in the early phases of 
the process Nevertheless, high amounts of chemo­
tactic factors must be released as soon as the anti­
bodies reach their targets That these chemotactic 
factors do not cause early accumulation of PMNs in 
the vessels can be explained as an effect of the early 
intravascular coagulation that obstructs the capillary 
lumens, especially at the base of the graft In later 
stages of the process, when severe extravasation of 
erythrocytes has taken place, followed by necrosis, 
PMNs can be seen in increased numbers in the inter-
stitium However, it is obvious in the histologic sec­
tions that these PMNs do not reach the graft via the 
obstructed graft vessels but are conveyed by the host 
vessels, which they leave at the demarcation line of 
the graft to move further via the interstitial tissues 
A surprising finding was that depletion of comple­
ment by COVF treatment caused a histologic type of 
vasculitis with the characteristics of an Arthus reac­
tion This seems not compatible with the generally 
held view that fixation of complement is an essential 
step in the Arthus reaction, because, by its activa­
tion, chemotactic substances are generated that at­
tract PMNs It is not clear how in our system of 
C-depleted recipients the initial leukotaxis is gen­
erated The primary attraction of PMNs can be the 
result of immune adherence of the PMNs to the Fc 
part of the antibodies, bound to the vascular endo­
thelium It has been shown that such adherence can 
occur without involvement of complement " As soon 
as the PMNs release lysosomal enzymes, either dur­
ing phagocytosis20 or independently from phagocyto­
sis,20"23 more chemotactic factors will be generated in 
a positive back loop system in which not only the en­
zymes themselves but also the damaged cells are par­
ticipants 2 4 In our system the effect is probably en­
hanced by the granulocytosis in the peripheral circu­
lation caused by the COVF treatment (Table 2) This 
effect of COVF treatment has been reported before,25 
as has been the finding that PMNs can accumulate at 
cutaneous Arthus sites after COVF treatment ' 2 S It is 
possible that apart from inducing granulocytosis, 
COVF treatment may change the membrane proper-
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ties of the PMNs directly in such a way that adhesion 
to exposed Fc parts is facilitated. There are, however, 
no data available to substantiate this hypothesis. 
One could argue that the occurrence of AAR in 
complement-depleted mice was caused by traces of 
complement activity not measurable in the hemolytic 
complement assay but still present after treatment 
with COVF. This residual activity might then have 
been sufficient to trigger the reaction after injection 
of a high dose of antibody. However, our previous 
finding that high doses of non-complement-fixing 
IgGl antibodies also caused AAR not only in mice 
with a normal complement status but also in COVF-
treated mice argues strongly for the involvement of a 
mechanism that is completely independent of com-
plement activation.' 
The finding that in COVF-treated recipients doses 
of MARO up to 2.0 ml could only elicit an Arthus-
like type of rejection shows that even very high doses 
of antibody cannot effectuate immediate endothelial 
cell lysis unless complement is activated. Apparently 
in the complement-depleted system early intravascu-
lar coagulation cannot occur as an initial event in the 
AAR. 
The differences in Arthus-like and Shwarzman-like 
patterns were most clearly present at the early stages 
of the process. Once necrosis of the graft had started, 
intravascular coagulation and PMN accumulation 
were seen in both types of rejection. Furthermore, 
even at early stages we sometimes found Arthus-like 
and Shwartzman-like reactions in the same graft 
when an intermediate dose of antibody had been 
given (Table 1, Group 4). Since small differences in 
concentration or activity of the immune reactants 
may completely alter the histologic picture, it may be 
very difficult to assess the actual destructive power of 
the different factors in clinical studies or in experi-
mental models wherein no inbred animals arc used. It 
is, therefore, not surprising that the findings in these 
situations are often controversial. 
In conclusion, our results show that complement 
can greatly amplify the immune vasculitis caused by 
antibody, while modifying its histologic pattern. On 
the other hand, the presence of complement is not 
absolutely required for the rejection, since AAR can 
still be induced in C3-dcpleted mice that have no 
measurable serum complement activity. Our finding 
that Arthus-like and Shwartzman-like types of graft 
rejection are part of one spectrum of antibody-medi-
ated vessel wall damage, in which the total of the 
destructive power of the combination of antibodies 
and complement determines the sequence of events to 
occur, may lead to a better understanding of the 
pathogenesis not only of the clinical and experimen-
tal graft rejection but also of the related forms of im-
mune complex vasculitis. 
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INTROBUCTION 
Studies on the role of polym 
in inflammatory and immun 
require the induction of PMN 
study. Conventional methods 
of treatment with cytostatic 
(Stetson and Good, 1951; 
Cochrane 1968; Hovat et 
antigranulocyte serum (Coc 
Cochrane, 1968; Simpson and 
Salant et al, 1980). Tre 
has been reported to be 
(Stetson and Good, 1951; С 
1968). In rats PMN deple 
anti-PMN serum, but the 
reproducible (Cochrane et al 
have not found reports о 
treatment with cytostatic dr 
our own results using these 
a ΡΓΝ depletion in mice to g 
a period of at least 5 
Therefore, we have used Tota 
method to effect neutroph 
report describes the effect 
mice, as compared with th 
induce PMN depletion. 
orphonuclear granulocytes (PMNs) 
ologic reactions in vivo often 
depletion m the animals under 
to reach this goal have consisted 
drugs, such as nitrogen mustard 
Cochrane et al 1959; Hawkins and 
al 1968), or treatment with 
hrane et al 1965; Hawkins and 
Ross, 1971; Forbes et al, 1976; 
atment with nitrogen mustard (HN2) 
especially effective in rabbits 
ochrane et al, 1965; Movat et al, 
tion is generally induced with 
effect does not seem to be very 
, 1965; Forbes et al, 1976). We 
f satisfactory results of either 
ugs or anti-PKN serum in mice, and 
methods in a model, that demanded 
ranulocyte counts below 150/μ1 for 
days, have been unsatisfactory. 
1 Body Irradiation (TBI) as a 
il depletion in mice. The present 
of TBI on blood cell counts in 
at of conventional methods used to 
MATERIALS AND METHODS 
Animals. Inbred strains of C57B1/10 mice, originally olîtained 
from the Jackson Laboratory (Bar Harbor, Г'аше), were kept in 
our laboratory by continuous brother-sister natings. The mice 
were used for the experiments at the age of 3-4 months. New 
Zealand white rabbits or goats were used to prepare 
anti-granulocyte serum. 
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Depletion of PNNs. To induce 
methods were employed: 
PMN depletion in mice three 
A. Treatment with nitrogen mustard (mechlore than!ne hydro­
chloride, UH2). Mice received i.ρ. inj ееtions of nitrogen 
mustard (Mustini HCl, Erocacef BV, Haarssen, The Hetherlands) 
at a dose of 1.75 mg/kg, on 4 subsequent days. To prevent 
infection the mice received daily Terramycin (Oxytetracycline, 
Pfizer) orally, in a dose of 7.5 mg (θ.15 ml), starting 2 days 
before treatment, and were kept in a laminar flow unit under 
aseptic conditions. 
B. Treatment with antigranulocyte serum. Anti-mouse granulo­
cyte serum was prepared with a modification of the method 
described by Cochrane et al (1965). In short: 4ml of a 0.13! 
w/v solution of glycogen in 0.15M saline was injected i.p. in 
mice. Four hours later the peritoneal cavity was washed with 
7ml heparinized (500 U/ml) saline. Thus obtained peritoneal 
exudates of 60 mice were pooled and the cells were washed 
twice with phosphate buffered saline (PBS). Contaminating 
erythrocytes were lysed with tris-ammoniumchloride 0,83?, and 
most of the platelets were eliminated by discarding the 
supernatants after repeated centrifugations at 100g. The 
number of cells obtained after terminal washings in PBS was 
1.5-2.4x10 , and the percentage of granulocytes was 65-70?. 
Attempts to enrich the suspension of PMHs by means of gradient 
cent rifugation failed because of considerable cell losses in 
this procedure, due to a large overlap in density between 
mouse granulocytes and lymphocytes. The cells were 
resuspended in 5 ml Ringer's solution, and, after mixture with 
5 ml complete Freund's adjuvant (CFA), injected s.c. in a 
rabbit or a goat. When rabbits were used a second 
immunization followed after four weeks, by i.v. injection of 
2x10 cells, and 7 days later the animals were bled. In 
goats the first s.c. immunization was followed by 5 weekly 
i.v. boosts of the same number of cells, and the animals were 
bled 7 days after the last immunization. Because in rats the 
peritoneal exudates, obtained by peritoneal washings after 
previous i.p. injection of 0.1? glycogen, contain 95? 
granulocytes, we also prepared anti-rat PMH serum in rabbits 
and goats, by repeated immunizations with 2x10 cells as 
described above. Part of the anti-PKN sera was absorbed with 
mouse erythrocytes, thymus and lymph node cells, platelets, 
and plasma, using 1 vol of packed cells and 0.2 ml of mouse 
plasma to 10 ml of antiserum. After sterilization by passage 
through a sterile 20ιημ filter (Schleicher and Schüll, Dassel, 
Germany) the sera were stored at -20 C. Mice that received 
anti-PMH serum were kept in a laminar flow unit and received 
antibiotic treatment as described under A. 
C. Total Body Irradiation. To effect PKH depletion the mice 
received a Total Body Irradiation (TBI) of 6.0 Gy (600rad). 
The irradiation was performed with an orthovolt X-Eay-unit 
(Stabilipan, Siemens) at 250 kV, filter Thoraeus II, resulting 
in a half value layer of 3·1 mm copper. The dose rate 
-1 was 0 . 2 0 Gy min" , and t h e f i e l d s i z e 15x20 a t a 
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focus-skin distance of 76.6 cm. Before undergoing TBI the 
mice were anaesthetized by an i.p. injection of sodium 
pentobarbital, 0.03 rag per g body weight (Narcovet, Apharma 
BV, Arnhem, The Netherlands) and placed between two perspex 
plates, the upper one being ?. mm thick. To minimize 
intestinal complications the TBI was preceded by 24 hr of 
fasting. To prevent infection the mice were kept under 
aseptic conditions in a laminar flow unit, from 2 days before 
until 21 days after the irradiation, while they received 
Polymyxin В (40 mg/l) and Neomycin (100 mg/l) in their 
drinking water, and heat sterilized food. 
Cell counting. Leukocytes in blood drawn from the retrobulbar 
plexus were either counted by a manual method, using a Pürker 
Hemocytome ter, or in an automatic electronic cell counter 
(Sysmex Toa). Manual counts were done in fourfold. The 
differences between the mean values counted by the electronic 
and the manual method, simultaneously performed in 6 groups of 
3-4 mice (at day 4 after TBI of 6.0 Gy) were less than 10% and 
within the error range of both methods. Differential counts 
were performed on May Grünwald Giemsa stained air-dried 
smears. If possible 200 cells were counted but in treated and 
especially in irradiated mice these numbers were not always 
present in the 2 or 3 blood smears of one mouse. In the 
studies on the effect of HN2 and antigranulocyte serum, 
platelets were counted in a Bürker Hemocytome ter using 
Feissly fluid for dilution. In the mice that received TBI, 
platelet counts were performed in a Thrombocounter С 
(Coulter). 
Complement assay. Serum complement activity was measured in a 
sensitive hemolytic assay using the method of Berden et al 
(1978). 
RESULTS 
Treatment with Nitrogen Mustard. The effects of treatment 
with Nitrogen Mustard (HN2) on the blood cell counts of the 
mice, after i.p. injection of a dose of 1.75 mg/kg on 4 
subsequent days, are shown in Table I. At 24 hr after the 3rd 
and 4th injection the number of PMNs were below 150/μ1 in only 
4 out of 7 mice. At 48 hr after the fourth injection the 
number of PKNs had already risen to 20-50$ of normal values in 
all mice. Meanwhile, repeated injections caused increasing 
toxic side effects and death losses were more than 20%. When 
the dose of HN2 was raised to 3·5 ng/kg PMN counts lower than 
100/ 1 could be obtained for a period of 24 hr after the 
fourth injection, but the surviving mice were too ill to be 
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Table I: Effect of treatment with Nitrogen Mustard, at a dose of 1.75 
mg/kg i.p. given on subsequent days, on the blood cell counts 
of adult male C57B1/10 mice 
No of i.p. 
Injections 
Time between 
Last Inji 
and Cell 
Counting 
24 
24 
24 
48 
sction 
(hr) 
Leukocytes 
/ui 
5200, 5000 
3800, 3600 
2600, 1400 
5600, 1500 
2000 
7700, 2600 
5100, 3900 
PMN 
h 
312, 
152, 
78, 
72, 
240 
580, 
204, 
s 
1 
210 
72 
42 
180 
260 
350 
Platelets 
χ 10"5/wl 
235, 240 
705, 640 
630, 725 
580, 590 
790 
1060, 985 
990,1070 
Controls 
(n-6) 
10,200+1600 1255+365 1120+250 
used for further experiments. As our experimental model 
required a stable PMN depletion to levels below 15θ/μ1 for at 
least 5 days, during which the mice had to remain in good 
condition, we considered treatment with НЫ2 unfit to reach 
this goal. As shown in Table I platelet counts were 
moderately affected by treatment with HN2. Following an 
initial dip to 20% their numbers remained at 50-70$ after 
repeated injections, with a quick recovery at 48 hr after the 
fourth treatment. Mononuclear cell numbers were reduced 
approximately parallel to those of granulocytes. 
Treatment with anti-granulocyte sera. Several pools of 
anti-PMN serum were used, and we varied the treatment from 
doses of 0.5 ml i.p., given at 16 to 18 hr and 2 to 4 hr 
respectively before cell counting, to doses of 1.0 ml twice a 
day on 5 subsequent days. However, even the high doses of the 
most efficient antisera did not induce a PMN depletion in 
which granulocyte levels were constantly below 150/vil in all 
animals. An illustration of representative effects of two 
doses of several pools of antiserun is given in Table II. The 
most effective anti-mouse-granulocyte serum (RAMGS-l) caused 
considerable toxic side effects, that were even more severe 
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Table II. Effect of treatment with different pools of anti-granulocyte 
serum on blood cell counta of C57B1/10 mice 
Serum 
Time between 
Last 
Injection 
Dose'·' and Cell Leukocytes 
(ml) Counting (hr) /μΐ 
.1) PMNs 
/VI 
Platelets 
χ 10"5/υ1 
RAMCS-I2) 
unabsorbed 
RAHGS-I 
absorbed 
HAKGS-II2' 
unabsorbed 
GAMOS3) 
unabsorbed 
RARGS4) 
unabsorbed 
Controls 
(n=6) 
0 
0 
1 . 
0, 
0 
1 . 
1 . 
.5 
.5 
.0 
.5 
.8 
.0
.0 
4 
24 
4 
4 
4 
4 
2 
4 
2 
4 
325 
2600 
1200 
1200 
2900, 2500 
6100, 2800 
4800, 7000 
2700, 5900 
2600, 3100 
2000, 1700 
10200+1600 
130 
260 
120 
16Θ 
780, 750 
1342, 700 
1440,1050 
890, 760 
470, 590 
200, 340 
1255+365 
520 
420 
350 
379, 292 
248, 370 
198, 486 
692, 110 
498, 598 
674, 800 
1120+250 
1) Two injections were given, the first 16-18 hr before the second. 
2) Rabbit-anti-mouse-granulocyte serum, pool I and II. 
3) Goat-anti-mouse-granulocyte serum. 
4) Rabbit-anti-rat-granulocyte serum. 
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Table III. Effect of TBI of 6.0 Gy on differential blood cell 
counta and platelets in adult male C57D1/10 mice 
Days 
after 
TBI 
3 
4 
5 
6 
7 
10 
Controls 
Ho. 
of 
mice 
5 
5 
5 
4 
3 
6 
6 
PI« s/yl 
+ SD 
44 
1Θ 
37 
66 
48 
25 
1255 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
16 
5 
17 
17 
24 
16 
365 
Hononuc 
cells/ν 
+ SD 
143 
82 
146 
134 
152 
161 
8865 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
lear 
1 
41 
5 
33 
17 
24 
46 
1487 
Platelets 
x10" 
+ SD 
1290 
1 190 
1005 
781 
736 
44 
1169 
Vul 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
207 
246 
214 
47 
96 
19 
176 
200 η 
150-
100-
50-
k loj 
• 
• 
• 
• 
I 
1 4 
• 
• 
• 
• 
1 
• 
ι 
11 
normal 
range 
days after TBI 
Fig. 1: The effect of TBI of 6.0 Gy on serum 
complement levels of adult C57B1/10 mice, 
calculated as the percentages of the CH50 
values of age and sex matched controls. 
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The effect of Total Body Irradiation: As shown in Table III 
the effect of TBI of 6.0 Gy caused a stable depletion of PMNs 
to levels below 1OO/μΙ for a period of 3 to 10 days after the 
irradiation. Furthermore, under the described aseptic regimen 
and antibiotic treatment the mice could be kept in a healthy 
condition, with a mortality of less than 5%· TBI in lower 
doses of 5.0 or 4.0 Gy caused a lesser degree of PMN depletion 
to values of 177 ?_ 31 (n = 3) and 170 +_ 46 (n = 4) per μΐ 
respectively on day 4 after the irradiation. Parallel to the 
depletion of PMNs, after TBI of 6.0 Gy a similar depletion of 
mononuclear cells was seen (Table III). The separate effects 
on lymphocytes and monocytes were not tested, mainly because 
the differentiation between these cells in the smears, which 
is normally already rather difficult, was further impaired by 
moderate degrees of nuclear pycnosis, due to the irradiation. 
The overall impression was that the percentage of monocytes 
among the mononuclear cells, normally amounting to 5-10¡o, was 
unaltered by the TBI. Although platelets were reduced in 
number from day 6 after TBI, their counts remained above 60$ 
of normal values in the first 7 days. A more substantial 
depletion was reached in the following days, proceeding to a 
level of about 5% of normal values on day 10 (Table III). The 
effect of TBI on serum complement levels was tested in 3 
groups of 6 otherwise untreated mice on days 4,7, and 11 after 
irradiation. The levels were calculated as percentages of the 
CH50 values of age and sex matched controls (fig. 1). The 
results demonstrate that in contrast to treatment with 
anti-PMN serum, TBI did not reduce the complement levels. 
DISCUSSION 
Our results show that for the induction of PKN depletion in 
mice TBI of 6.0 Gy is the method of choice. Major advantages 
of this approach as compared to treatment with cytostatic 
drugs or antigranulocyte serum are: l) The effected PKN 
depletion is severe, consistent and stable, and lasts for a 
period of at least 7 days. 2) By keeping the mice under 
aseptic conditions and by protective treatment with 
antibiotics the animals can be kept healthy and active, with 
few losses, and subsequent procedures, such as intravenous 
injections for experimental purposes, can be easily performed. 
3) During the critical period of PMN depletion no injections 
are required to keep the PMNs at low levels, which diminishes 
the risk of infection. 4) TBI does not significantly affect 
serum complement levels. 5) TBI is relatively easy to 
administer and time consuming immunizations and absorptions of 
antisera are not required. 
Side effects of TBI are the concomitant depletion of 
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lymphocytes and platelets. The effect on platelet counts can 
he largely circumvented by choosing day 4-7 after TEI as the 
time for experimental procedures, since in this period 
platelet counts remain above 60% of normal values. The number 
of lymphocytes, however, drops simultaneously with that of 
PMNs. In experimental situations in which lymphocyte 
depletion may be critical, reconstitution with isogeneic 
lymphoid cells immediately after TBI could, at least in part, 
compensate for the loss of lymphocytes. An undesirable 
lowering of lymphocyte and platelet counts was also a side 
effect of the treatment with НЫ2 and anti-ΡΓΝ sera. Major 
disadvantages of these conventional methods, however, are the 
inconsistent effect on the PMN levels and the severe toxicity. 
In all treatments that cause illness of the mice, it has to be 
kept in nind that dehydration and shock of the animals 
substantially impair the peripheral circulation. This effect 
can be critical when the experimental challenge concentrates 
on organs depending on the peripheral circulation such as the 
skin. Illustrative for this effect are our findings in an 
experimental model in which we tested the role of PMNs in the 
acute antibody mediated rejection of skin xenografts in mice 
(in preparation). We found that treatment with rabbit 
anti-rat-PMK serum prevented the rejection, although the PMN 
depletion was insufficient (200-400 PMNs/μΐ). To exclude a 
non specific reaction we repeated the experiments with mice 
that received anti-lymphocyte serum instead of anti-PMN serum, 
in similar high doses, that also caused moderate illness in 
the mice. We found the same preventing effect on the 
rejection, although the PMN counts remained normal. We 
concluded that the results of the treatment with anti-PMN 
serum, that falsely suggested a PMN dependency of the 
antibody-mediated rejection, were either due to an impaired 
peripheral circulation, thus preventing the antibody to reach 
the graft in sufficient amounts, or to a decrease in 
complement levels, caused by the anti-PMN serum. This 
assumption was supported by the finding that in mice that 
received TBI the rejection was not prevented, despite severe 
PMN depletion. 
Theoretically, the most attractive aspect of treatment with 
anti-granulocyte serum is its specificity. However, the 
preparation of effective, specific, and non-toxic 
anti-mouse-PMN serum has proved to be very difficult. The 
procedure is impaired by the fact that mice m general have 
very low PMN counts as compared to other animals such as rats 
or rabbits, and that it is not possible to induce peritoneal 
exudates that contain 90% or more PI'Ks like in rats. The 
overlap in density between mouse lymphocytes and granulocytes 
further impedes purification of the suspension to be used for 
immunization. Moreover, absorption of the anti-PIiN sera with 
mouse lymphocytes and platelets did not prevent the depressive 
effect on lymphocyte and platelet levels. A similar finding 
has been reported by Simpson et al (1971 ), about the effect of 
54 
abso 
the 
was 
comp 
f oun 
геро 
prot 
that 
conv 
the 
cri t 
indu 
rbed ant 
guinea-
no t meas 
lement 1 
d a deer 
rted no 
ocol (Wi 
repeat 
entional 
complem 
ical if 
ced infl 
i-gu 
pigs 
ured 
evel 
ease 
rmal 
nn e 
ed 
ant 
ent 
the 
amma 
m e a 
. I 
Τ 
s se 
to 
co 
t al 
in je 
i ser 
leve 
mode 
tory 
-pig 
η th 
he e 
ems 
valu 
mple 
, 19 
ctio 
um w 
Is о 
1 is 
pro 
-PMN 
is s 
ffec 
to b 
es b 
ment 
73). 
ns 
ill 
f th 
use 
cess 
serum 
tudy t 
t of a 
e vari 
elow 1 
valu 
Howe 
with 
cause 
e anira 
d for 
es . -
on the 
he effe 
nti-PMN 
able . 
0# in 4 
es in a 
ver
 F it 
high d 
с oncomi 
als. Τ 
the stu 
lymph 
сt on 
serum 
In our 
mice 
simi 1 
is t 
oses о 
tant f 
his ef 
dy of 
ocyt 
plat 
on 
exp 
test 
ar e 
o b 
f an 
lue t 
feet 
immu 
e leve 
elet с 
the 
erimen 
ed. 0 
xperim 
e exp 
у effe 
uation 
ean b 
noiogi 
Is of 
ounts 
serum 
ts we 
thers 
ental 
ec ted 
ctive 
s in 
ecome 
cally 
We conclude, that for PMN depletion in mice TBI is a 
relatively easy and very reliable method, that should be 
considered the method of choice especially in those 
experiments in which a concomitant depletion of lymphocytes is 
acceptable. 
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CHAPTER 5 
ACUTE ANTIBODY-MEDIATED REJECTION OF SKIN GRAFTS WITHOUT 
INVOLVEMENT OF GRANULOCYTES OR COMPLEMENT 
M. José J.T. Bogman, Ine M.H.A. Cornelissen 
and Robert A.P. Koene 
ABSTRACT 
In immunosuppressed mice that carry rat зкіп xenografts acute 
antibody-mediated graft rejection (AAR) can be induced by 
intravenous administration of mouse anti-rat globulin. 
Dependent on the amount of antibody injected and on the 
complement status of the recipient an Arthus-like or a 
Shwartzman-like pattern of vasculitis occurs. The role of 
polymorphonuclear granulocytes (PMNs) in either type of 
vasculitis was tested by inducing AAR in recipients depleted 
of PMUs by Total Body Irradiation. Despite the absence of 
PMNs in the graft vessels, AAR occurred both in the 
Arthus-like and in the Shwartzman-like type. Moreover AAR 
could be elicited in PMN depleted recipients that were 
complement depleted by Cobra Venom Factor treatment or were 
congenitally C5 deficient. We conclude that neither PMNs nor 
complement are essential mediators in this form of 
antibody-mediated vasculitis. 
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INTRODUCTION 
The characteristic presence of large numbers of 
polymorphonuclear granulocytes (PMNs) in various types of 
immune vasculitis has suggested an important role for these 
cells as mediators in immunologically induced vessel wall 
damage. The first experimental model in which this role was 
extensively studied was the Arthus reaction and in this model 
PMNs proved to be essential mediators in the induction of 
endothelial damage (1-3)· Acute vasculitis with intravascular 
accumulation of PMNs is also present in grafts that are 
acutely rejected by circulating antibodies directed against 
the graft antigens. This similarity to the Arthus reaction 
(4-7) led to the hypothesis that PKNs were also essential in 
the acute antibody-mediated graft rejection (AAR). However, 
studies that tried to prove this have given contradictory 
results (8-10). 
Since in the acute antibody-mediated graft rejection also 
patterns of vasculitis have been described that resemble the 
experimental generalized Shwartzman reaction (4, 6, 7, 11, 12) 
we have thought that some of the controversies could possibly 
be explained by the fact that the morphological sequence of 
events in the AAE can vary, and that the role of PMNs may be 
dependent on the way wherein the initial damage to the 
endothelial cells takes place. In previous studies on skin 
allografts and xenografts in mice we have shown that the 
pattern of acute antibody-mediated rejection is indeed 
variable and can either resemble an Arthus reaction, in which 
PMNs seem to play an important role in the first phases of the 
antibody-induced vasculitis, or can be consistent with a 
Shwartzman-type of vasculitis, that is characterized by early 
intravascular coagulation, and in which PMNs morphologically 
seem to play only a secondary role. Which histological type 
of rejection will occur after injection of specific antibodies 
against the donor tissue depends on several factors, such as 
the immunologic difference between host and graft, the amount 
of antibodies in the circulation of the recipient, and the 
availability of complement. When we used an allograft model, 
in which immunosuppresaed mice carrying skin allografts were 
intravenously injected with specific antibody, acute rejection 
of the graft could only be elicited when together with the 
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antibody аізо exogenous complement was injected. This 
rejection of allografts always developed along an Arthus-like 
pattern (13)· In a xenograft model, in which iramunosuppressed 
mice carried rat skin grafts, the intravenous injection of 
anti-rat antibody could readily provoke acute rejection of the 
grafts without addition of exogenous complement. This 
rejection of xenografts showed a Shwartzman-like pattern when 
high doses of antibody were administered, whereas low doses 
caused a more gradually evolving vessel wall damage, 
histologically consistent with an Arthus-type of vasculitis 
(6). Similarly, manipulations in the amount of available 
complement in this xenogeneic model caused radical changes in 
the reaction pattern of the grafts. Complement depletion of 
the recipients changed the reaction in the graft vessels after 
injection of a high dose of antibody from a Shwartzman-like 
into an Arthus-like one. Conversely, an Arthus-like reaction 
could be changed into a more violent Shwartzman-like one when 
together with a low dose of antibody highly effective rabbit 
complement was administered (7). 
Considering the morphologic differences between the 
Arthus-like and the Shwartzman-like responses we felt that the 
role of PKNs should be separately studied for either type of 
vasculitis. Therefore we chose for our present study the 
xenogeneic model of rat skin transplanted onto 
immunosuppressed mice, in which system we can consistently 
induce either type of rejection by merely varying the amount 
of injected antibody (6). As in this system AAR can also be 
elicited in complement depleted or complement deficient mice, 
provided that the dose of antibody is sufficiently raised 
(7, 14, IS), we were also able to study the role of PMNs in 
the absence of complement. 
Our results show that PMNs are not essential mediators in the 
initial damage to the endothelial cells of the graft vessels, 
neither in the Shwartzman-like nor in the Arthus-like type of 
AAR. Moreover, we found that even in the absence of 
complement activity AAR can be elicited in PMN-depleted 
recipients, although PMNs proved to be important accelerators 
and amplifiers of the ultimate necrosis of the graft. 
MATERIALS AND METHODS 
Animals. Inbred strains of C57B1/10 and B10.D2 old 
(congeni tally C5 deficient) mice were originally obtained from 
the Jackson Laboratory (Bar Harbor, Maine) and inbred PVG/c 
rats from the Institute of Psychiatry, Bethlem Royal Hospital, 
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Beckinham (Kent, U.K.)· In our laboratory these atrains were 
kept Ъу continuous brother-sister matings. Mice were used for 
the experiments at ages of 3 to 4 months. Random bred goats 
were used to prepare anti-mouse lymphocyte serum. 
Antisera. Kouse anti-rat lymph 
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Transplantation procedure. Squares of 0.8 χ 0.8 cm 
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Acute rejection studies. On day 8 after grafting, when all 
grafts were in excellent condition and showed no signs of 
rejection, the mice received MARG via an i.v. injection into 
the tail vein. Macroscopic aspects and histologic features of 
the resulting graft destruction were studied. AAR was defined 
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as complete macroscopic necrosis of the graft within the next 
few days. In general this complete necrosis took place within 
72 hr, but in the irradiated and complement-depleted mice the 
progression of graft destruction was slower. This slower type 
of rejection was only considered to be mediated by the 
injected antibody if reaction was seen within 24 hr after 
injection and necrosis was macroscopically complete at least 7 
days before the first signs of rejection were visible in 
grafts of control mice that had not received MARC. 
Complement depletion. Serum complement activity was measured 
in a sensitive hemolytic assay (l7)· Complement depletion was 
induced by Cobra Venom Factor (COVF), 100 U/ml, (Cordis Ltd., 
Miami, Fla), administered from day 6 after transplantation in 
daily i.p. injections of 20 U. This dose regimen lowers the 
serum complement activity to unmeasurable levels from 24 hr 
after the first injection (15). On day 8 after 
transplantation the i.p. injection of COVF was given 2 hr 
before i.v. injection of MARG. Treatment with COVF was 
continued until rejection was complete, or, if no rejection 
occurred, for maximally 10 days. 
PMN depletion by Total Body Irradiation: Mice were depleted 
of PMNs by Total Body Irradiation (TBI ) consisting of a single 
dose of 6.0 Gy (600 rad) on day 4 after transplantation, at a 
dose rate of 0.20 Gy min" , from a 250 kV X Ray source 
(Stabilipan, Siemens). After 24 hr of fasting the mice were 
anesthetized by an i.p. injection of sodium pentobarbital, 
0.03 mg per g body weight (Narcovet, Apharma BV, Arnhem, The 
Netherlands-) and placed between two perspex plates, the upper 
plate being 2 mm thick. To prevent a potentially damaging 
effect of the irradiation on the endothelium of the graft a 
small piece of lead (12 χ 12 χ 3 mm), was placed on the upper 
perspex plate, just above the graft. The side scatter dose on 
the graft tissue, as measured in a phantom set-up (18) was 
20-25$ of the total dose of 6.0 Gy. To prevent infection the 
irradiated mice were kept under aseptic conditions in a 
laminar flow unit from 2 days before until 3 weeks after TBI, 
while they received Polymyxin В (40 mg/l) and Neomycin 
(100 mg/l) in their drinking water, as well as heat sterilized 
food. This regimen kept the mice in excellent condition 
throughout the experiment and mortality was less than 10$. 
Only irradiated mice that also received COVF for several days 
showed a deterioration of condition whicn was reversible after 
withdrawal of the COVF treatment. 
Counting of PMNs and Platelets. Leukocytes in blood, drawn 
from the retrobulbar plexus, were counted in a Bilrker 
Hemocytome ter. We compared the manual counts, that were done 
in fourfold, with simultaneous counts performed on an 
automatic electronic cell counter (Sysmex ToA). 
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The differences between the mean values in 6 groups of 3-4 
mice were less than 10^, and within the error range of both 
methods. Differential counts were performed on May Grünwald 
Giemsa stained air dried smears. Platelets were counted in a 
Thrombocounter С (Coulter). 
Histologic examination of the grafts. Skin grafts and 
surrounding tissue were removed at different times after the 
intravenous injection of MARG and fixed in 4% buffered 
formalin. From parrafin-embedded tissue blocks 4μ sections 
were cut and stained with hematoxylin and eosin (КАЕ), Giemsa, 
Goldner trichrome stain, elastic van Gieson stain, and 
Mallory's Phosphotungstic acid hematoxylin (PTAH) stain. The 
histologic descriptions are based on findings in at least 2-3 
mice per observation point. 
Table I. Effect of TBI (6.0 Gy) on PMN and platelet counts 
in the peripheral blood of male C57B1/10 mice 
D a y s 
a f t e r 
3 
4 
5 
Ё 
7 
10 
C o n t r o ] 
T B I 
. 3 
P P N / i 
4 4 
1 8 
3 7 
6 6 
4 8 
2 5 
1 2 5 5 
j l + 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
S . D . 
16 
5 
17 
17 
2 4 
16 
3 6 5 
P i a l be] 
1 0 " У / ] 
1 2 9 0 
1 1 9 0 
1 0 0 5 
781 
7 3 6 
44 
1 1 69 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
Í e t s χ 
L + S . D . 
2 0 7 
2 4 6 
2 1 4 
47 
96 
19 
176 
N o . o f 
m i c e 
5 
5 
5 
4 
3 
6 
6 
RESULTS 
Depletion of PMNs. Before turning to TBI for PMN depletion we 
tried to reach this goal by using the earlier published 
approaches of treatment with anti-PMN sera and cytostatic 
drugs. Anti-PMN sera were raised in rabbits or goats, 
according to the method of Cochrane (19) and administered in 
multiple i.p. injections on the days of and immediately 
before and after the injection of MARG. The resulting 
PMN depletion varied with this treatment and could not be 
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1 ) 2) 
Table II. PHN counts in immunosuppressed and irradiated recipients 
of PVG/c skin grafts after administration of MARG 3) 
COVF4) 
treat­
ment 
-
-
-
-
-
+ 
+ 
+ 
+ 
+ 
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plan­
tation 
θ 
9 
10 
1 1 
Η 
θ 
9 
10 
1 1 
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32+24( 
31+41 
46 + 35 
55 + 21 
30 + 16 
38 + 22 
48 + 30 
86 + 43 
24 + 10 
n.t. 
Circulating PHN/ 
C57B1/10 
;ed 
10)5) 
(4) 
(3) 
(3) 
(3) 
(8) 
(5) 
(4) 
(2) 
Control 
1474+607(12) 
889+318 
n.t. 6) 
n.t. 
n.t. 
(4) 
2998+1005(12) 
2007^ 244 
1558 
1748 
n.t. 
(3) 
(1) 
(1) 
ul + S.D. 
BIO. 
PHN 
depleted 
16+16(4) 
42+22(3) 
42+12(2) 
4i 1(5) 
89+22(4) 
13+ 6(5) 
25+ 9(5) 
36+18(5) 
20+12(2) 
40+24(2) 
D2 old 
Control 
1500+307(3) 
862+382(3) 
683^273(2) 
421+382(5) 
n.t. 
1782+465(8) 
189+ 66(2) 
537+ 66(2) 
1024+264(2) 
554 (1) 
1) To postpone cellular rejection the mice received ALS i.p. on days 
- 2 , - 1 , 0, 2, and 4 after transplantation. In mice that were 
irradiated on day 4 after transplantation the injection of ALS on 
day 4 was omitted. 
2) TBI (6.0 Gy) to induce PHN depletion was given on day 4 after 
transplantation. 
3) HARG (0.01ml in complement normal and 2.0ml in C5 deficient and 
COVF treated mice) was given i.v. at day 8 after transplantation. 
4) 20 U COVF was given i.p. from day 6 -14 after transplantation or 
until rejection was complete. 
5) No. of animals tested given in parentheses. 
6) n.t.: not tested. 
sustained for the duration of the experiment. This also held 
for treatment with nitrogen mustard. Furthermore, the mice 
became increasingly ill after repeated injections of both 
nitrogen mustard or anti-PMN serum. Extensive absorptions of 
the anti-PMN serum with mouse lymphocytes, erythrocytes, 
platelets, and plasma could not prevent this. Lastly, the 
anti-PMN serum caused considerable decreases in complement 
levels of the recipients (less than 10$ of control mice). We 
have previously shown that this greatly impairs the 
sensitivity to AAR (7). 
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The i n f l u e n c e of TBI on t h e n u m b e r s of PMNs i n t h e c i r c u l a t i o n 
of o t h e r w i s e u n t r e a t e d C57B1/10 m i c e i s shown i n T a b l e I . 
S u b s t a n t i a l d e p l e t i o n of p l a t e l e t s d i d n o t o c c u r i n t h e f i r s t 
7 d a y s a f t e r TBI ( T a b l e 1 ) . PMN c o u n t s t h a t w e r e p e r f o r m e d i n 
mice t h a t were s a c r i f i c e d f o r h i s t o l o g i c e x a m i n a t i o n of t h e 
g r a f t s a t d i f f e r e n t t i m e s a f t e r t h e i n j e c t i o n of MARC, a r e 
shown i n T a b l e I I . Mice were c o n s i d e r e d PMN d e p l e t e d when t h e 
number of PMNs i n t h e c i r c u l a t i o n was l e s s t h a n 1 5 0 / u l . T h i s 
c o n d i t i o n was r e a c h e d on day 3 a f t e r TEI and r e m a i n e d s t a b l e 
f o r a t l e a s t 10 s u b s e q u e n t d a y s i n a l l e x p e r i m e n t s . The 
i n f l u e n c e of TBI on t h e c o m p l e m e n t l e v e l s of i m m u n o s u p p r e s s e d 
mice t h a t c a r r i e d r a t s k i n g r a f t s was m e a s u r e d i n two g r o u p s 
of 6 m i c e on day 8 a f t e r t r a n s p l a n t a t i o n . The mean v a l u e s +_ 
SEM of t h e CH50 t i t e r s were 25 ^ 5 U/ml and 43 ± 30 U/ml f o r 
t h e i r r a d i a t e d g r o u p s v e r s u s 38 +_ 10 U/ml and 73 ^_ 27 U/ml 
r e s p e c t i v e l y f o r n o n - i r r a d i a t e d b u t o t h e r w i s e s i m i l a r l y 
t r e a t e d c o n t r o l g r o u p s , c o r r e s p o n d i n g t o d e c r e a s e s i n 
c o m p l e m e n t l e v e l s i n t h e i r r a d i a t e d g r o u p s t o 66% and 59% of 
c o n t r o l v a l u e s r e s p e c t i v e l y . 
I n f l u e n c e of PMN d e p l e t i o n on AAR i n g r a f t r e c i p i e n t s w i t h a 
n o r m a l c o m p l e m e n t s t a t u s . The e f f e c t s of i . v . i n j e c t i o n of 
d i f f e r e n t d o s e s of mouse a n t i - r a t g l o b u l i n (MARC) i n mice 
c a r r y i n g r a t s k i n g r a f t s a r e shown i n T a b l e I I I . I n j e c t i o n of 
h i g h d o s e s of a n t i b o d y on day 8 a f t e r t r a n s p l a n t a t i o n 
Table I I I . Inf luence of PKK d e p l e t i o n on AAR of PVG/c skin 
grafted onto immunosuppressed C57B1/10 r e c i p i e n t s 
2) O c c u r r e n c e of AAR 
Croup Dose of MARC 
N o . 1 ) (ml) C o n t r o l mice PMH-depleted mice 
1 
2 
3 
4 
5 
6 
0.25 
0.10 
0.01 
0.0075 
0.005 
_ 
θ / 8 8/8 
8/ θ 7 / 7 
7/12 9/13 
0/12 1/10 
0 / 6 0 / 6 
0 / 8 0 / 9 
i ) I n e a c h dose g r o u p age and sex matched mice were t r e a t e d 
w i t h t h e same pool of CAMLS and i n j e c t e d w i t h s i m i l a r 
a l i q u o t a of d i l u t e d MARO i n s i m u l t a n e o u s e x p e r i m e n t s . 
2) Number of mice wi th c o m p l e t e m a c r o s c o p i c n e c r o s i s of t h e 
g r a f t s w i t h i n 72 h r / n u n b e r of mice t e s t e d . 
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invariably caused rejection of the grafts within 72 hr, both 
in PKN-depleted recipients and in control mice (group 1 and 
2) . At 2 hr after the injection of MARG both groups showed 
cyanosis of the grafts. In the PMN-depleted mice this 
reaction was somewhat less intense. Also when low doses of 
antibody were administered (group 3-5) there were no essential 
differences in the fate of the grafts between PMN-depleted and 
control groups. Injection of 0.01 ml of MARG caused a 
red-blue discoloration of the grafts within 24 hr in both 
PMN-depleted and PMN-normal mice although the reaction in the 
PMN-depleted animals was again somewhat less severe. 
Similarly in the groups that received 0.0075 ml of MARG the 
control mice showed only slightly more hyperemia of the grafts 
in the first 48 hr after injection than the irradiated mice. 
Both groups that received 0.005 ml of MARG showed transient 
edema and in some cases slight hyperemia of the grafts with no 
evident difference between PMN-depleted and control mice. In 
these groups as well as in most of the grafts in the groups 
that received 0.0075 ml of MARG the reaction was reversible. 
The MST of these grafts was not significantly different from 
that in control animals that had not received MARG. 
On histologic examination the grafts in the control groups 
that received high doses of MARG, i.e. 0.25 and 0.10 ml 
(groups 1 and 2), showed, at 2 hr after injection, vessel wall 
destruction, intravascular platelet aggregation, and bleeding, 
consistent with our earlier results (6) (Fig 1 A ) . At 24 hr 
there was progression to subtotal or total necrosis of the 
graft tissue. In the PMN-depleted groups that received 0.25 
and 0.10 ml of MARG the grafts showed, at 2 hr after injection 
of the antibody, also evident vascular damage, platelet 
aggregation, and extravasation of erythrocytes, although the 
reaction was somewhat less severe than that in the control 
groups (Fig. 1 В). Total to subtotal necrosis, with 
obliteration of the vessels by intravascular coagulation was 
present at 48 hr. Of the groups that received the low dose of 
0.01 ml of MARG the control grafts showed, at 2 hr after 
injection, vasodilation and hyperemia, accompanied by 
accumulation of PMNs in the vessels. At 8 hr these changes 
had increased and platelet aggregation, vessel wall damage, 
and extravasation of erythrocytes were prominent features. In 
the PMN-depleted mice that received 0.01 ml of MARG the damage 
to the vessel walls was strikingly the same, apart from the 
conspicuous absence of PMNs. Endothelial swelling and 
vasodilation were seen at 2 hr and vessel wall destruction 
with local platelet aggregation and bleeding were obvious at 
8 hr. As could be expected from the macroscopic observations 
the vasodilatation and hyperemia were somewhat less in the 
PMN-depleted group when compared with the control group. The 
eventual fate of the grafts however, was the same 
(Table III, group 3 ) . 
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Figure 1. Reaction in the vessels of PVG/c skin grafted onto 
C57B1/10 recipients at 2 hr after injection of 0.25ml FARG. 
Both in control mice (A) and in PKN-depleted mice (В) 
dilation of the vessels is seen, with platelet aggregation 
along the vessel walls (arrows), and partial destruction of 
the endothelial cells. (A and B: Gierasa, 80x). 
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Table IV. Influence of PMH depletion on AAH of PVG/c skin grafted onto 
immunosuppressed COVF-treated and/or C5 deficient raice 
Dose of 
Recipient Croup MARG 
strain No. (ml) 
COVF PMN 
treat- deple-
ment tion AAR 1) 
Days after grafting 
on which macroscopic 
necrosis was complete 
C57B1/10 1 
B10.D2 old 3 
2.0 
2.0 
1 .0 
1 .0 
2.0 
2.0 
2.0 
2.0 
11/11 9-14 
0/9 (15-20) 
Θ/8 9-12 
11/14 11-14 (19,22,24) 
9/9 9-13 
8/8 10-13 
1 1 / 1 1 9 - 1 1 
1 0 / 1 0 1 0 - 1 3 
1 1 / 1 1 9 - 1 1 
Θ/10 1 2 - 1 4 ( 2 2 , 2 6 ) 
2) 
1) Number of mice with complete macroscopic necrosis of the graft/number 
of mice tested. 
2) Survival times of grafts that were rejected later than day 14 or that 
were unaffected by the injected KARG are given in parentheses. 
the antiserum, the PMN-depleted 
hyperemia and edema at 24 hr, 
after 96 hr. In most of the PMN-
slowly progressed to total ne 
showed partial recovery, after 
occurred between 19 and 24 day 
microscopic events in the grafts 
treated C57B1/10 mice consiste 
endothelium in the graft vessels 
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48 hr. PMNs were absent in the g 
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destruction, extensive bleeding, 
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with progression t 
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Subsequently we studied the effect of PMN depletion in 
genetically C5 deficient B10.D2 old recipients. The results 
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Figure 2. Reaction in the vessels of PVG/c skin grafted onto 
COVF-treated B10.D2 old mice, at 8 hr after injection of 
2.0ml MARG. A: The grafts in recipients with normal PMN 
counts show extensive vessel wall damage, with PMN 
infiltration, intravascular platelet aggregation (arrows), 
and bleeding (HSE, lOOx). B: In PMN-depleted recipients the 
reaction is less severe, but nevertheless vasodilation is 
present with intravascular platelet aggregation (arrows) and 
partial disappearance of endothelial cells. (HSE 8 0 X ) . 
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(groups Ъ and 4). In PMH-depleted B10.D2 old mice that also 
received COVF treatment (group 5) the microscopic events were 
comparable to those in similarly treated C57B1/10 mice 
(group 2 ) , i.e. moderate dilation and hyperemia of the 
vessels at 8 hr with local platelet aggregation (Pig. 2B), 
slowly proceeding to necrosis after several days. Control 
mice, treated with COVF but not PMN-depleted, showed at 8 hr 
extensive PMN infiltration in addition to platelet aggregation 
and bleeding (Fig. 2k). 
In the complement normal groups as well as in the complement 
depleted and complement deficient groups, virtually no PMNs 
could be found in the sections in the first 8 hr after 
injection of KARG, neither in the graft vessels nor in the 
recipient tissue of the PMN-depleted animals. At later 
stages, from 24 hr, only very few PMNs were present, located 
in the interstitial tissue along the borderline between graft 
and host, apparently recruited to this area from the few 
numbers in the circulation. Migration of these PMNs into the 
graft was seen only at the time of incipient necrosis. By 
this time their number had gradually increased but was still 
very low and only a small fraction of the large numbers of 
PMNs that could be seen from 2 hr in the non-irradiated 
control groups. 
DISCUSSION 
In antibody-mediated rejection of skin and whole organ grafts 
the major histocompatibility antigens on the endothelial cells 
are the primary target for the immunologic attack. We have 
not analyzed the distinct specificities of antibodies present 
in our antirat serum, because there is sufficient data that 
xenogeneic sera prepared in a similar way in several species 
contain antibodies against these antigens. Indeed, it was 
with a xenogeneic rabbit antimouse serum that the H2-complex 
of the mouse was first discovered (20). More recent evidence 
can be derived from a report that rabbit antirat sera detect 
rat allo-antigens (21), and from the finding that mouse 
monoclonal antibodies against rat allo-antigens can be raised 
after immunization with rat erythrocyte or splenic antigens 
(22). 
Studies on the role of PMNs in the AAR have resulted in 
conflicting reports in the literature. Forbes et al (9) found 
that AAR in cardiac allografts could be elicited in the 
absence of PMNs, whereas Wartenberg et al (10) induced an in 
vitro "rejection" of rabbit and rat hearts by perfusion with 
allogeneic antisera that contained complement but no 
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Our results show that although PMNs play a role as amplifiers 
and accelerators of tissue necrosis induced by acute 
antibody-mediated vasculitis, they are not essential mediators 
in the basic damage to the endothelial cells, initiated by the 
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binding of antibody to the antigens located on the cell 
membrane. The outcome of the experiments in irradiated 
recipients with a normal complement system that received high 
doses of antibody was not surprising, as we have shown earlier 
that in these cases a Shwartzman-like type of rejection can be 
seen, characterized by early platelet aggregation without 
preceding accumulation of PKNs in the graft vessels (6). 
However, for the acute rejection developing after 
administration of low doses of antibody we expected PI'Hs to be 
essential, as in this type of vasculitis destruction of the 
endothelial cells was preceded by accumulation of PMNs in the 
vessels (6). The appearance of PKNs was even more impressive 
in complement depleted mice, wherein large doses of antibody 
were necessary for the induction of AAR (7). The results of 
the present study prove that our previously held hypothesis of 
an essential role for PMNs as mediators in the endothelial 
destruction in the Arthus-like type of rejection is no longer 
tenable. In complement normal recipients one can assume, as 
has been suggested by others (24-26), that the binding of 
antibody to the endothelial cell membrane may be followed by a 
complement induced cytolysis. If this assumption is right, 
the finding that PMNs are not essential mediators implies that 
the morphologic differences between the Shwartzman-like and 
the Arthus-like types of AAR may be mainly a consequence of a 
difference in the velocity of the lytic reaction. When the 
total damaging potential of antibody and available complement 
is sufficient to cause immediate endothelial cell lysis, the 
thrombogenic subendothelial structures will cause early 
platelet aggregation. The resulting vasculitis will thus 
resemble the generalized Shwartzman reaction, in which the 
endothelial cells are destroyed by bacterial endotoxins. On 
the other hand, if the amounts of antibody and/or complement 
are only sufficient to effect a moderate, more slowly 
developing damage to the endothelial cells, the process of 
cell lysis and subsequent platelet aggregation will take 
several hours. In this situation platelet aggregation is 
microscopically not visible behore 8 hr after injection of the 
antibody. Meanwhile the chemo tactically attracted PKNs 
dominate the morphological picture and as the initial partial 
endothelial damage is not easy to detect, this sequence of 
events simulates that of an Arthus reaction. 
The assumption of complement induced cytolysis as the basic 
event in the AAR does not explain the occurrence of AAR in 
COVF treated or C5 deficient recipients. One could argue that 
in COVF treated mice unmeasurable traces of complement could 
still be operative. However, it is generally assumed that C5 
deficient mice completely lack the ability to form the lytic 
complex of complement. We also were unable to detect 
measurable levels of hemolytic complement activity in this 
strain (17). Moreover, the finding of Perden et al (15) that 
AAR could be induced by injection of purified 
non-complement-fixing IgG1 subclass antibodies, strongly 
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suggests that a complement independent mechanism can be 
effective in the AAR. Since our results show that PMNs cannot 
be hold responsible for the complement-independent cell 
damage, one has to consider other mechanisms by which large 
amounts of antibody can induce cell destruction. The recent 
study of Soper et al (27), who reported lysis of 
antibody-coated cells by platelets in the presence of early 
complement components, has focussed new attention on a 
possible cytolytic effector role for platelets. We cannot 
exclude that cytolysis by platelets is responsible for the 
endothelial cell damage in our experiments with 
complement-normal and C5 deficient mice, but it is hard to see 
how this can occur in COVF treated mice, which lack the early 
components that are necessary for platelet induced lysis. 
Another destructive mechanism that could possibly be involved 
in the neutrophil and complement independent endothelial cell 
damage is antibody-dependent cell-mediated cytoxicity (ADCC), 
in which mononuclear effector cells such as macrophages can 
adhere to antibody-bearing cells by means of their Fc 
receptors. There is evidence that this phenomenon, which has 
mainly been described in in vitro systems, can also be 
effective in vivo and this activity is not inhibited by Cobra 
Venom Factor treatment (28). In the histologic sections we 
could find no indication that mononuclear cells played a role 
in the initiation of the vasculitis. Also other experimental 
data suggestive for a destructive role for macrophages in the 
initial phase of antibody-induced immune vasculitis are 
lacking. However, this does not exclude a possible effector 
role for these cells, and it is conceivable that 
radioresistent monocytes, macrophages, or other Fc-receptor 
bearing effector cells induce the cell damage. 
We now have evidence that also allogeneic mouse skin grafts 
can be destroyed by specific alloantibody in the absence of 
PMNs (29). This raises the question whether this 
PMN-independent destructive mechanism can be operative in 
other forms of antibody-mediated vasculitis and therefore also 
in the classical Arthus reaction. It is generally held that 
in the Arthus reaction damage to the endothelial cells is 
caused by the release of lysosomal enzymes from PMNs that have 
been attracted by chemotactic action of activated complement 
factors. However, there is some evidence that PMNs are not 
completely indispensable. Cochrane has found that the Arthus 
reaction can take place in the absence of PMNs if very high 
doses of antibody are injected (1). Also in a related 
Arthus-type reaction, evoked by intradermal injection of high 
doses of antibody to basement membrane, vessel wall damage 
could be induced in the absence of both complement and PKNs 
(1). Furthermore, the occurrence of complement and neutrophil 
independent glomerular injury after injection of high doses of 
antibody against glomerular basement membrane has been fairly 
well established in several models of experimental nephritis 
(19, ЗО), which share many similarities with both the Arthus 
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reaction and certain typea of human glomerulonephritis. The 
pathogenesis of these types of complement and PMN-independent 
injury is thus far unknown. 
In conclusion, our results show that in the AAR PMNs are not 
essentially involved in the initial attack on the endothelial 
cells, caused by the binding of the antibody to the antigen on 
the cell membrane. This implies that for the basic damage to 
the endothelial cell membrane other factors are responsible. 
In complement normal recipients this may be a direct lytic 
effect induced by the activation of complement. However, the 
mechanism of endothelial cell damage that can be elicited by 
high doses of antibody in the absence of complement and PMNs 
remains to be clarified. 
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CHAPTER 6 
POLYMORPHONUCLEAR GRANULOCYTES ARE NOT ESSENTIAL 
FOR THE ACUTE ANTIBODY-MEDIATED REJECTION OF 
MURINE SKIN ALLOGRAFTS 
M. José J.T. Bogman, Ine M.H.A. Cornelissen, 
and Robert A.P. Koene 
Transplantation, in press. 
ABSTRACT 
The role of polymorphonuclear granulocytes (PMNs) in the acute 
antibody mediated rejection (AAR) was studied in a murine skin 
allograft model. B10.A akin was grafted onto B10.D2 
recipients that were treated with goat anti-mouse lymphocyte 
serum, to postpone cellular rejection. This prolonged the 
median survival time of the grafts to 21.5 ±_ 1.0 days. PMN 
depletion was effected Ъу a Total Body Irradiation of 6.0 Gy 
on day 4 after grafting, which reduced the number of PMNs in 
the circulation to levels below 150/yl from day 3 to 10 after 
the irradiation. To induce AAR the mice received, on day 8 
after grafting, an i.v. injection of a monoclonal antibody 
with specificity against the donor H-2K antigen together 
with 0.25ml fresh rabbit serum. This caused acute rejection 
of all grafts in the control group within 72 hr, with abundant 
presence of PMNs in the graft vessels on histologic 
examination. In PKN depleted recipients the reaction in the 
grafts was somewhat retarded in the first 24 hr, but 
nevertheless acute rejection occurred within 72 hr in 9 of 11 
animals, whereas PMNs were virtually absent from the grafts. 
The results show that PMNs act as accelerators and amplifiers 
of the acute antibody mediated rejection process, but are not 
essential mediators in the damage to the vascular endothelium 
of the grafts. 
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In previous studies of our group it was shown that in 
immunoauppressed mice that carried skin allografts, hyperacute 
rejection can be induced by intravenous injection of specific 
antibody, directed against the graft tissue, together with an 
efficient exogenous complement (5, 8 ) . Morphologically, the 
first reaction after injection of antibody and complement was 
edema, dilatation of the graft vessels, and accumulation of 
PMNs in the vessels, present at 30 min and maximal at 2-4 hr. 
The early presence of PMNs led to the hypothesis that these 
cells were attracted by chemotactic factors generated by the 
binding of antibody to antigen and the activation of 
complement, and that they were essential or at least very 
important effectors in the damage to the endothelial cells, by 
means of their release of lysosomal enzymes during 
phagocytosis of the immune complexes. The aim of the present 
study was to test the influence of PMN depletion on 
antibody-mediated rejection of skin allografts. 
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MATERIALS AND METHODS 
Animala. Inbred strains of B10.D2/new Sn(H2d) and B10.A (H-2k) 
mice, originally obtained from the Jackson Laboratory (Bar 
Harbor, Maine), were kept in our laboratory by continuous 
brother-sister matings. A goat, used to prepare anti-mouse 
lymphocyte serum, was bought on the local market. Fresh 
frozen serum of New Zealand white rabbits was used as a source 
of сomplement· 
Antisera : Goat anti-mouse lymphocyte serum (GAMLS) was 
prepared as described earlier (9). Cells that produce the 
monoclonal antibody coded 11-4.1 , which recognizes the 
specificity H-2K (10), were kindly provided by the Salk 
Institute, San Diego, CA. The antiserum 11-4.1 was produced 
in ascites fluid using BALB/c mice. The cytotoxic titer, 
determined in a trypan blue exclusion assay using B10.A spleen 
cells, was 1:5x10 . 
Transplantation procedure. Squares of 0.8 χ 0.8 cm full-
thickness skin of female B10.A mice were grafted onto the 
flanks of 3-4 months old female B10.D2 recipients by a 
modified fitted graft technique (8). The fate of the grafts 
was followed by daily macroscopic inspection. The grafts were 
considered to be rejected when no viable epithelium remained. 
Median survival times (MST) and standard errors were 
calculated according to the method of Litchfield (11). To 
postpone cellular rejection of the grafts the recipients were 
treated with GAMLS on days -2, 0, 2, and 4 after grafting in a 
dose of 0.25 ml i.p. The MST of the grafts under this regimen 
was 21.5 ± 1.0 days. In the mice that received TBI on 
day 4 after transplantation the injection of GAMLS on day 4 
was omitted. Under these conditions the MST of the grafts was 
23.3 ^ 1.2 days. 
PMN depletion. Mice were depleted of PMNs by Total Body 
Irradiation ("TBI) in a single dose of 6.0 Gy (600 rad), on day 
4 after transplantation, at a dose rate of 0.20 Gy min , 
from a 250 kV X Bay source (stabilipan, Siemens). To 
undergo TBI the mice were, after 24 hr of fasting, 
anaesthetized by an i.p. injection of aodium pentobarbital, 
О.ОЗ mg per g body weight (Narcovet, Apharma BV, Arnhem, 
The Netherlands) and placed between two perspex plates, the 
upper plate being 2 mm thick. The grafts were covered with a 
small piece of lead (12x12x3 mm) to prevent irradiation 
damage to the endothelial cells of the graft. The side 
scatter dose on the graft tissue, as calculated in a phantom 
set up was 20-25$ of the total dose of 6.0 Gy. From two days 
before until 3 weeks after TBI the mice were kept under 
aseptic conditions in a laminar flow unit, and received 
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Polymyxin В (40 mg/l) and Neomycin (100 mg/l) in their 
drinking water, as well аз heat sterilized food. Under this 
regimen the irradiated mice remained in good condition. 
Acute rejection studies. To induce acute antibody mediated 
r e j e c t i o n ( A A R ) t h e mice received, at day 8 after 
transplantation, an i.V. injection of the monoclonal antibody 
11-4.1 in a dose of 3200 cytotoxic units (CTU), together with 
0.25 ml fresh rabbit serum (HC). One CTU was defined as the 
amount of alloantibody lysing 50% of 1.25 x 10 BIO.A cells 
in a cytotoxic trypan blue exclusion assay. AAR was defined 
as macroscopic necrosis of more than 80$ of the graft tissue 
within 72 hr after the injection of antibody and RC. 
Histologic examination of the graft. For histologic 
examination representative grafts and surrounding recipient 
tissue of the PMN-depleted and the control mice were excised 
at point 8, 24, and 72 hr after injection of antibody and RC. 
After fixation in buffered formalin and embedding in paraffin, 
4μ sections were cut and stained with hematoxylin and eosin 
(HAB), Giemsa, Goldner's trichrome stain, and Mallory's 
Phosphotungstic acid hematoxylin stain. 
RESULTS 
PMN depletion. TBI of 6.0 Gy invariably caused a rapid fall 
of PMNs in the peripheral blood of the mice to values lower 
than 150/μ1 (in 30% of the animals even lower than 100/μΐ) and 
these values remained at this low level from day 3 to 10 after 
irradiation (in preparation). The effect of the TBI in the 
present experiment was monitored by counting PMNs in blood 
drawn from the retrobulbar plexus of two mice of the 
irradiated and the control group at day 8 (0 hr and 8 hr after 
the injection of antibody and RC) and of three mice of each 
group at day 11 (72 hr after injection). Mean numbers of PKNs 
in the mice of the irradiated group were 41/μΙ (θ hr) and 
25/μ1 (8 hr) at day 8, and 22/μ1 at day 11 after 
transplantation. In the control group the corresponding 
numbers were 1153, 2948, and 676. Platelet numbers were also 
reduced by TBI but in the first 7 days after the irradiation, 
i.e. the period in which AAR developed, the counts always 
remained above 50% of normal values. 
Acute rejection. AAR was induced on day 8 when the grafts 
were in excellent condition and showed no signs of rejection. 
The effects of an i.v. injection of 3200 CTU of monoclonal 
antibody 11-4.1 combined with 0.25 ml RC are shown in Table I. 
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T a b l e I . The i n f l u e n c e o f PMN d e p l e t i o n on t h e o c c u r r e n c e 
o f AAR i n BIO.A s k i n g r a f t e d o n t o i m m u n o s u p p r e s a e d 
B 1 0 . D 2 r e c i p i e n t s 
. PMN . A c u t e A n t i b o d y 
T r e a t m e n t ' D e p l e t i o n M e d i a t e d R e j e c t i o n 
9/9 
9/11 
0 / 1 0 (MST 2 1 . 5 + 1 . 0 d a y s ) 
0 / 1 0 (MST 2 5 . 3 i 1 .2 d a y s ) 
1) S p e c i f i c a n t i - H 2 - K m o n o c l o n a l a n t i b o d y was i n j e c t e d i . v . 
on d a y 8 a f t e r t r a n s p l a n t a t i o n , i n a d o s e o f 3 2 0 0 CTU, 
t o g e t h e r w i t h 0 . 2 5 ml f r e s h r a b b i t s e r u m ( R C ) . 
2) PMN d e p l e t i o n was induced by TBI of 6 .0 Gy on day 4 a f t e r 
t r a n s p l a n t a t i o n . 
3) Number of mice with necros i s of more than 80% of the 
graf t t i s s u e within 72 hr a f te r i n j e c t i o n of antiserum and 
RC/number of mice t e s t e d . 
The r e s u l t s d e m o n s t r a t e t h a t AAR c o u l d n o t o n l y be i n d u c e d i n 
c o n t r o l mice h u t a l s o in P K N - d e p l e t e d r e c i p i e n t s . 
M a c r o s c o p l c a l l y t h e r e a c t i o n of t h e g r a f t s i n b o t h g r o u p s was 
e s s e n t i a l l y t h e s a m e , a l t h o u g h i n t h e P M N - d e p l e t e d g r o u p t h e 
d e v e l o p m e n t of t h e u l t i m a t e n e c r o s i s was somewhat r e t a r d e d . 
At p o i n t 2 h r a f t e r i n j e c t i o n a l l g r a f t s showed edema and some 
r e d - b l u e d i s c o l o r a t i o n , t h e r e a c t i o n i n t h e PMN-dep l e t ed g r o u p 
b e i n g s l i g h t l y l e s s i n t e n s e . At 8 h r most of t h e g r a f t s i n 
t h e c o n t r o l g r o u p showed c y a n o s i s and p a r t of them p a t c h y 
b l e e d i n g . I n t h e P M N - d e p l e t e d g r o u p c y a n o s i s o c c u r r e d i n 
a b o u t 50% of t h e g r a f t s , and o n l y few had s i g n s of b l e e d i n g . 
At 48 h r a l l g r a f t s of t h e c o n t r o l g r o u p were c o m p l e t e l y 
n e c r o t i c , w h e r e a s i n t h e PMN-dep le t ed g r o u p t h i s was t h e c a s e 
i n 3 o u t of 1 1 . However , a t 72 h r 9 ou t of 11 of t h e 
P M N - d e p l e t e d a n i m a l s had t o t a l t o s u b t o t a l (80$ or more) 
n e c r o s i s of t h e i r g r a f t s , p r o c e e d i n g t o r e j e c t i o n . The two 
r e m a i n i n g g r a f t s p a r t l y r e c o v e r e d from t h e i n i t i a l c y a n o s i s 
and b l e e d i n g , and were e v e n t u a l l y r e j e c t e d a t days 22 and 24 
a f t e r t r a n s p l a n t a t i o n . 
G r a f t h i s t o l o g y . M i c r o s c o p i c e x a m i n a t i o n of t h e g r a f t s i n t h e 
c o n t r o l g r o u p showed , a t 8 h r a f t e r i n j e c t i o n of a n t i b o d y and 
RC, marked d i l a t i o n and c o n g e s t i o n of t h e v e s s e l s , a c c o m p a n i e d 
by v e s s e l w a l l d e s t r u c t i o n , p l a t e l e t a g g r e g a t i o n , and b l e e d i n g 
( f i g . 1 A ) . Many PMNs were p r e s e n t i n t h e v e s s e l s and i n t h e 
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F i g u r e 1 . V a s c u l a r r e a c t i o n i n t h e g r a f t s a t 8 h r a f t e r i n j e c t i o n o f 
a n t i b o d y a n d c o m p l e m e n t . ^ . T h e c o n t r o l g r o u p s h o w s m a n y PMNs i n a n d 
a r o u n d t h e v e s s e l s , s e v e r e v a s c u l a r d a m a g e , a n d p l a t e l e t a g g r e g a t i o n 
( a r r o w ) . ( G i e m s a 1 0 0 x ) . _B. I n t h e PHN d e p l e t e d g r o u p no PMNs a r e s e e n . 
N e v e r t h e l e s s e n d o t h e l i a l d a m a g e a n d p l a t e l e t a g g r e g a t i o n ( a r r o w ) a r e 
e v i d e n t . ( G i e m s a 1 6 0 x ) . 
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DISCUSSION 
Our results show that in the AAR of mouse akin allografts, 
induced by intravenous injection of specific antibody and 
complement, PMNs are not essential for the induction of the 
initial endothelial damage, although these cells have an 
accelerating and amplifying effect in the secondary events 
that lead to the ultimate graft destruction. This finding is 
consistent with data in the literature reporting the 
occurrence of AAR in cardiac allografts in rats in the absence 
of PMNs (6), and the induction of an in vitro "rejection" of 
rabbit and rat hearts by perfusion with allogeneic antisera 
containing complement but no lymphocytes or granulocytes (7). 
On the other hand it was found that in mice carrying rat skin 
xenografts PMN depletion prevented the AAR induced by 
injection of antirat globulin (4). Considering the 
controversial conclusions from studies on different models we 
originally assumed that these could be explained by the fact 
that the AAR of allografts and xenografts can take place along 
different patterns, i.e. either along an Arthus-like or along 
a Shwartzman-like type of vasculitis (2-4, 12). As the Arthus 
type of AAR is characterized by early PMN accumulation in the 
vessels of the graft and the Shwartzman type by early 
intravascular platelet aggregation, the pathogenesis of the 
initial endothelial damage may be essentially different in 
these two types. PMNs may be essential mediators in the 
Arthus-like AAR, whereas platelets may play an important role 
in the Shwartzman-like type. However, in a rat to mouse skin 
xenograft model, in which we were able to change an 
Arthus-like pattern of AAR into a Shwartzman-like one by 
simply modifying the amounts of injected antibody and 
available complement (9, 13), we could not prevent the 
occurrence of AAR in either type by depleting the recipient 
The results in the present 
findings in the xenograft 
mice of PMNs (in preparation) 
report are consistent with these 
model and are in favor of the hypothesis held by several 
authors (3, 7, 14) that the initial damage to the graft 
endothelium is caused by a direct cytolytic effect of the 
binding of antibody to the antigen on the cell membrane and 
the subsequent activation of complement. Platelet aggregation 
to the damaged vessel walls may subsequently amplify the 
process. Furthermore, there is recent evidence that mouse 
platelets can have a direct lytic effect on antibody coated 
cells if early complement components are present (15). Such a 
hypothesis is only valid for those conditions wherein an 
efficient complement is available. In our allograft model 
this can be effected by injection of a heterologous complement 
together with the antibody (5). However, the AAR of rat 
xenografts in mice does not require such an exogenous 
complement source. We have previously shown that in this 
model AAR can also be induced in recipients that are 
congenitally complement deficient or complement depleted by 
treatment with Cobra Venom Factor (9, 16). Under these 
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conditions the amount of antibody, necessary to induce AAR is 
substantially higher than in complement-normal recipients, but 
nevertheless AAR does take place, even in the absence of PI'IIs 
(in preparation). Our present data give no further insight in 
these PMN- and complement-independent mechanisms. 
In conclusion we have shown that PMNs are not essential 
mediators in acute antibody-mediated rejection of mouse skin 
allografts, although they can amplify and accelerate the 
reaction. It seems likely that the basic damage to the 
endothelial cells is brought atrout either by direct complement 
mediated cytolysis of endothelial cells with consequent 
platelet aggregation and vascular obstruction or by platelet 
mediated cytolysis of endothelial cells. 
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Variable expression of Ia 
antigens on the vascular 
endothelium of mouse skin allografts 
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la antigens are membrane-bound glycoproteins that play a 
part in antigen recognition and subsequent cell-cell interactions 
in the immune response. In the mouse they are coded for by 
the / region of the major histocompatibility complex H-2 and 
have been demonstrated on В lymphocytes, monocytes, acti­
vated Τ cells, macrophages and dendritic cells, including 
Langerhans cells1,2. la-like antigens have also been detected 
on the vascular endothelium in man3-6 and on epidermal 
keratinocytes in rats7'8 but expression on the latter cells was 
induced by a graft-versus-host reaction or by contact hyper­
sensitivity . In the mouse, previous studies have suggested that 
la antigens in skin are restricted to epidermal Langerhans cells 
and it was thought that these were the targets for la-dependent 
rejection of skin allografts. The results presented here show 
that la antigens in mouse allografts are also present on the 
vascular endothelium but their expression is variable and 
dependent on the immunological status of the recipient. These 
findings suggest that vascular endothelial cells can act as targets 
in la-incompatible skin allograft rejection. 
We investigated the presence of la antigens in mouse skin 
allografts and the localization of these antigens by in vivo 
injection of labelled anti-la alloantibodies. A monoclonal anti-
la IgG2a alloantibody, raised in our laboratory in BALB/c 
{H-2d) mice against BALB/K (H-2k) donor cells, was used. 
The Iak determinant recognized by this antibody was shown to 
map in the I region by a positive binding reaction with 40-50% 
of BIO . AQR (Iak) spleen lymphocytes and a negative reaction 
with BIO . Τ (6R) (la4) cells. These strains differ only at the I 
and S region of the H-2 complex. The anti-la antibody was 
labelled with 1 2 5I using the chloramine-T method10 and aliquots 
of approximately 5 χ 104 c.p.m. were injected intravenously 
(i.v.) into otherwise untreated female B10.D2 (tf-2d) 
recipients of BIO . BR {H-2k) and BALB/c (Н-2а) tail skin 
allografts on day 6 after transplantation. The grafts were excised 
after different time intervals and the amount of radioactivity 
was determined by γ-counting of the entire graft. 
Figure 1 shows that specific binding of the anti-la antibodies 
to the BIO. BR grafts occurred, with a maximum at 8-12 h 
after injection. In the BALB/c control grafts a background 
binding level was observed after each time interval. To localize 
the bound radioactive antibodies, В10. BR skin grafts were 
excised 16 h after injection and prepared for autoradiography 
(see the legend to Fig. 2). Microscopic examination showed 
that the bound radioisotope was localized in the vessel walls 
of the donor skin (Fig. 2a). The vessels of the recipient, visible 
in a rim of tissue surrounding the graft, were negative in all 
cases. All other structures of donor origin, including the epider­
mis, were also negative. To identify the localization of the vessel 
wall associated la antigens more precisely, the monoclonal 
anti-la was labelled with biotin and the conjugate was 
administered as outlined above. After excision of the grafts 
cryosections were prepared and developed with avidin conju­
gated with fluorescein. The capillary endothelial cells were then 
identified in the same sections by incubation with rabbit anti­
serum against factor VIII antigen, which is a specific marker 
for endothelial cells1 1 1 2, followed with rhodamine-conjugated 
goat anti-rabbit IgG serum. Both labels completely overlapped, 
which showed that the cells that bind the anti-la antibodies are 
^
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 " · · BIO.BR —>B10.D2 
. , β BALB/c —B10.D2 
τ 1 1 1 r 
0 2Ί ΊΘ 72 9 6 
Time after injection(h) 
Fig. 1 Binding of 125l-labelled anti-Iak monoclonal IgG2a to 
BIO.BR ( · · ) and BALB/c (О O) skin allografts in 
vivo. Female BIO . D2 recipients were injected intravenously on 
day 6 after transplantation with 0.1 ml phosphate-buffered saline 
containing 0.1% bovine albumin and 3.8xl04c.p.m. of radio-
label. After different time intervals the recipients were killed, the 
grafts excised, and the amount of radioactivity determined. Each 
point represents the mean value of two measurements. 
cells of the vascular endothelium (Fig. 2b, c). In control skin 
allografts from BALB/c (Η-2ά) donor mice, binding of 
biotinylated anti-Iak antibodies was undetectable. The binding 
of a control monoclonal antibody (WT3, raised against human 
Τ lymphocytes) that was injected into BIO . D2 recipient mice 
carrying BIO . BR allografts was also negative. 
In these experiments we had observed a correlation between 
the binding of labelled anti-la antibodies and the degree of 
rejection. Grafts showing macroscopic signs of rejection bound 
considerably more antibody than healthy grafts. Perhaps 
expression of donor strain la antigens on the vascular 
endothelium of the allograft might be influenced by the immune 
response of the host. To investigate this, donor tail skin was 
transplanted onto immunosuppressed and nude recipients. In 
vivo binding studies were performed at day 7 after transplanta­
tion by i.v. injection of radiolabelled monoclonal anti-la anti­
body followed by excision and γ-counting of the skin grafts 
16 h after injection. The results of these experiments are shown 
in Table 1. A high binding of anti-la antibodies was observed 
if donor skin from mice carrying Iak antigens (BIO. BR or 
B10.AQR) was grafted onto untreated normal recipients. 
Background levels of binding were seen if the donor skin lacked 
the Iak antigens (B10.D2), even in the presence of an H-2 
incompatibility between donor and recipient (ΒΙΟ.Τ (6R)-» 
BIO. D2) Similar results were obtained with the monoclonal 
anti-I-E/C11 antibody coded 14-4-4 which was prepared by 
Ozato et al.13 (data not shown). In recipients treated with 
immunosuppressive agents such as rabbit anti-mouse lym­
phocyte serum or cyclosporin A (Cy A), there was also only 
background binding of radioactivity in skin grafts of Ialt-positive 
donors, demonstrating the dependence of endothelial la antigen 
expression on the immune response of the host (Table 1). A 
binding inhibition assay showed that the anti-mouse lymphocyte 
serum did not contain anti-la xenoantibodies that could inter­
fere with the in vivo binding studies (data not shown). If 
congenitally athymic BALB/c nu/пи mice, which lack a T-
dependent immune system, were used as recipients of BIO . BR 
grafts, binding of the radiolabelled anti-Ia to the donor tissue 
did not occur either, suggesting that the lack of la-binding is 
due to the absence of an immune response and not to a direct 
interaction between the immunosuppressive drugs and the 
endothelial cells. The absence of binding of anti-la in these 
allografts was confirmed by immunofluorescence; on day 62 
after transplantation on nude recipients, no positive fluores­
cence staining was observed on donor endothelial cells. 
We have also examined anti-la binding after withdrawal of 
immunosuppressive treatment. In this experiment, BIO . T(6R) 
recipients of B10.AQR skin grafts received daily CyA and 
the uptake of monoclonal la antibody by the graft was assessed 
Fig. 2 α, Autoradiomicrograph showing the localization of 
12
 iodine-labelled monoclonal anti-la IgG2 in BIO. BR skin 
allografts after passive administration to BALB/c recipients in 
vivo. x31. Male recipient mice were injected intravenously at day 
6 after transplantation with 0.1 ml phosphate-buffered saline 
(PBS) containing 0.1% bovine albumin and 17xl0 4 c.p.m. of 
25I-labelled anti-Iak IgG2. Grafts were removed after 16 h and 
put in neutralized 4% formaldehyde solution. After fixation and 
imbedding, 5-μπι paraffin sections were cut and transferred to 
gelatinized slides. The sections were deparaffinated, rinsed in 
distilled water and dipped in photographic emulsion (Nuclear 
Research Emulsion, Ilford K5, 3 χ diluted with water) in the dark. 
The slides were air-dried overnight in a humid atmosphere at 
room temperature and then left for 4 weeks in sealed boxes at 
4 °C. After exposure the emulsion was developed with developing 
fluid (Kodak), and the sections were stained with haematoxylin 
and eosin. Photomicrographs were made with black and white 
film (Agfapan-25) using a green filter. The localization of the 
intravenously injected anti-la antibody is clearly visible as a posi­
tive staining of the vessel walls of the graft (arrows). The vessels 
of the recipient are negative (arrowhead). 6, Micrograph showing 
the localization of biotin-labelled anti-Iak in a BIO. BR skin 
allograft after passive administration to a BIO. D2 recipient in 
vivo. The figure shows the presence of fluorescein isothiocyanate-
42 
labelled anti-la antibodies on the endothelium of the graft, demon­
strating the presence of donor la antigens. x78. 1 mg of mono­
clonal IgG2a was conjugated with 120 μg of the ¿V-hydroxysuc-
cinimide ester of biotin (Sigma) in 1 ml of 0.1 M NaHCOj at room 
temperature. 100 μΙ of the conjugate were injected intravenously 
on day 6 after transplantation of both a BIO. BR and a BALB/c 
graft onto an untreated BIO . D2 recipient. After 2 h the grafts 
were excised and frozen in liquid nitrogen. Cryosections 4-5-μιη 
thick were air dried, fixed in acetone for 10 min and washed with 
PBS. The sections were then incubated in avidin-FITC (Sigma), 
diluted 500x in PBS containing 0.1% bovine serum albumin 
(BSA), and washed again. Subsequently the tissue sections were 
incubated with rabbit antiserum against human factor VIII antigen 
(Red Cross, Amsterdam) diluted lOOx, washed and developed 
with goat antiserum against rabbit IgG, conjugated with 
rhodamine (Cappel), diluted 50x. Finally the sections were rinsed, 
mounted in Aquamount (Gurr) and examined under a Leitz Dialux 
fluorescence microscope, equipped with Ploemopak epi-
illuminator and filter combinations for fluorescein and rhodamine 
labels, c. Using the filters for rhodamine fluorescence, the binding 
of the anti-factor VIII antibodies is shown in the same section as 
in Ь demonstrating the presence of factor VIII antigen on the 
endothelium. x78. 
at different days after transplantation. In five mice the CyA 
administration was discontinued on day 14. This leads to rejec­
tion of the skin grafts within 10-13 days14. The results show 
that withdrawal of the immunosuppressive agent resulted in 
uptake of radiolabel within 3 days. In the group that received 
CyA throughout, binding was not detectable at any time 
(Fig. 3). 
Our results show that donor type la antigens are present on 
vascular endothelium of skin allografts in the mouse. Their 
expression increases at the onset of rejection, whereas T-cell 
deficiency or administration of immunosuppressive agents sup­
presses it. Subsequent withdrawal of immunosuppression 
3,000 -
E 
α. 
ш 
e 
•3 
с 
2,0 0 0 -
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• · CyA daily 
о — - o CyA until day 14 
—г 
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—г 
12 6 8 1 0 12 l<t 1É 
Day after transplantation 
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Fig. 3 Binding of 125]-]abelled anti Iak monoclonal IgG2a to 
BIO AQR skin allografts in vwo Sixteen female BIO T(6R) 
recipients of BIO AQR grafts daily received 75 mg kg - 1 cyclo­
sporin A (Sandoz) orally, dissolved in olive oil at a concentration 
of 20 mg m l - 1 After different time intervals binding of radio-
labelled апІі-Іак was determined For this, recipient mice were 
injected intravenously with 4 Ox 104 с p.m and killed 16h later, 
to determine the amount of binding in the allograft At day 14 
after transplantation the remaining 8 mice were divided in two 
groups, one in which the immunosuppression was continued and 
one in which the administration of cyclosporin A was stopped 
Most of the points represent the mean value of 2-3 measurements 
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Table 1 Binding of radioiodinated anti-Ia11 monoclonal antibodies to mouse skin allografts at day 7 after transplantation 
Donor 
BIO. BR 
B10.D2 
B10.T(6R) 
BIO. BR 
BIO. BR 
B10.AQR 
BIO. AQR 
BIO. BR 
B10.D2 
Recipient 
BALB/c 
BALB/c 
B10.D2 
B10.D2 
B10.D2 
B10.T(6R) 
B10.T(6R) 
BALB/c nu/nu 
BALB/c nu/nu 
H-2 haplotype 
kn-d 
d-»d 
y2->d 
k^d 
k - d 
y l - y 2 
yl-+y2 
k - d 
d-od 
No. mice 
5 
5 
6 
10 
10 
6 
5 
8 
5 
Treatment 
— 
— 
— 
— 
RAMLS* 
— 
Cyclosporin A+ 
— 
— 
Binding±s.d. (c.p.m.) 
2,900 ±750 
350±100 
510±80 
2,500 ±600 
330±90 
2,038 ±650 
370±10 
450±100 
390±150 
* Rabbit-anti-mouse lymphocyte serum (0.25 ml) was injected intraperitoneally at days 0, 2 and 4 after transplantation. 
t Cyclosporin A (Sandoz) was dissolved in olive oil at a concentration of 20 mg т Г 1 and administered orally (75 mg per kg, daily). 
results in reappearance of the la antigens. A variable expression 
of la antigens has also been found on mouse peritoneal 
macrophages15"17. la expression on these cells is regulated by 
a lymphokine elaborated by activated Τ cells18 which is similar 
to immune interferon19. 
It seems likely that the expression of la antigens on vascular 
endothelium in our system is also under the influence of acti­
vated Τ cells. This would explain why endothelial la antigens 
have never been found in normal mouse skin apart from on 
epidermal Langerhans cells. We did not observe binding to 
cells in the epidermis. It is, however, possible that these cells 
could not be reached by sufficient amounts of antibody to be 
detectable by autoradiography. After administration of high 
doses of antibody, labelled with biotin, we have observed 
occasional binding to basal keratinocytes. 
Our results suggest that, in skin grafting across la incom­
patibilities, where la antigens on passenger cells initiate the 
immune response, the same antigens present on vascular 
endothelium are the primary targets for the rejection process. 
This latter assumption is supported by a study in allografts of 
human skin, which showed that microvascular damage invari­
ably preceded epithelial necrosis20. This could explain the 
contradictory results obtained with skin from bone marrow 
chimaeras grafted to la-incompatible recipients21. If syngeneic 
skin, repopulated with allogeneic /-region incompatible 
passenger cells is transplanted, rejection does not occur. This 
could be because in these skin grafts allogeneic la-positive 
endothelial cells are not available as targets. On the other hand, 
allogeneic skin grafts repopulated with cells syngeneic to the 
recipient are also often not rejected in /-region incompatible 
combinations. Under these circumstances the endothelial la 
antigens will not be expressed, because the syngeneic passenger 
cells fail to stimulate the immune response of the recipient. 
We thank the staff of the animal laboratory for technical 
assistance, Drs P. Faaber for the radioiodinations, the research 
group of the department of rheumatology for advice in the 
autoradiography procedure. Miss A. de Vries and Mrs Y. 
Stammes for typing the manuscript. The anti-I-E/Ck mono­
clonal antibody was obtained via Dr С. Melief. 
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CHAPTER 8 
GENEHAL DISCUSSION 

GENERAL DISCUSSION 
Acute antibody-mediated rejection аз a model of antibody-
induced vasculitis 
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Immune vasculitis, defined as immunologically induced 
necrotizing vessel wall destruction, is either the hallmark or 
an accompanying feature of many clinical syndromes. Among 
these are polyarteritis nodosa, systemic lupus erythematosus 
(SLE), rheumatoid arthritis, Henoch Schönlein purpura, 
Wegeners' disease, and several forms of glomerulonephritis. A 
great deal of the present knowledge of the pathogenesis of 
immune vasculitis has been derived from studies in 
experimental models. The various ways in which experimental 
types of vasculitis are induced, and the histological and 
clinical differences in the resulting inflamnatory processes, 
have led to different concepts of the pathogenesis of vessel 
wall damage, and analogous hypotheses have heen developed with 
regard to the causes of clinical syndromes that histologically 
resemble the experimental models. However, considering the 
vast amount of clinical and experimental studies that have 
concentrated on the mechanisms involved in the different types 
of vasculitis, and the unmistakable progress that has been 
made, the questions raised largely outnumber the answers that 
have been given, and, thus far, surprisingly little is known 
about the essential factors that in a given individual on a 
given time, lead to the occurrence of immune vasculitis. 
Like in the antibody-mediated graft rejection the study of the 
pathogenesis of immune vasculitis can focus on three main 
levels: 1) the antigenic targets, 2) the biologic properties 
of antibodies or immune complexes, and factors determining 
their deposition in the vessels, and 3) the role of host 
factors and mediator systems. 
In the vast majority of clinical syndromes associated with 
vasculitis the antigen is unknown, even in those diseases in 
which "immune complexes" can be demonstrated in the 
circulation. (in these cases the term "immune complexes" is 
used for aggregated immunoglobulins rather than for 
antigen-antibody complexes). It is obvious that in 
experimental models of vasculitis the antigen is at least 
roughly known, since it is either injected or used to prepare 
the antibodies. Nevertheless, a complex antigen such as 
glomerular basement membrane material or brush border antigen, 
evokes a polymorphic antibody response directed against 
multiple antigenic determinants, and even in these 
experimental models the exact way how and when the antibody 
reacts with the antigen is not always clear. 
That antibodies are involved in many types of vasculitis has 
been inferred from the demonstration of immunoglobulins in the 
vascular lesions. However, the binding of antibody and 
antigen or the deposition of immune complexes in the vessel 
walls is not sufficient by itself to cause tissue damage. In 
the resulting inflammation and necrosis 
effector systems of the host must be essentially involved. 
Many of the studies on mediator systems in immune vasculitis 
have concentrated on the classic candidates for effector roles 
in immunologically induced tissue damage: the complement 
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system, polymorphonuclear granulocytes (PKNs), platelets, and 
the coagulation system. The suggestion that these systems 
were essentially involved came originally from microscopic 
studies of the vascular lesions, that often showed a 
characteristic PMN accumulation or extensive platelet 
aggregation and intravascular coagulation. Still, the ways in 
which different mediator systems bring about the ultimate 
lesion are far from clear, and data from experimental models 
are controversial. 
To illustrate current opinions on pathogenic mechanisms in 
immune vasculitis we will refer to a restricted number of 
experimental models and discuss the factors involved in the 
induction of the vasculitis in these models as compared to our 
findings in the acute antibody-mediated rejection (AAR), with 
special emphasis on the action of mediator systems. For this 
purpose we have chosen 5 basic types of experimental immune 
vasculitis: the Arthus reaction, acute and chronic 
experimental serum sickness, the Passive Heymann Nephritis 
(PHN) and Nephrotoxic Nephritis (NTH). 
In the classic Arthus reaction a local necrotizing vasculitis 
is induced by intradermal injection of antigen in an animal in 
which specific antibodies are circulating in the blood (2,3). 
Antigen, antibody, and complement can be demonstrated along 
the vessel wall by immunofluorescence, and in the electron 
microscope the reactants appear to be deposited between and 
beneath the endothelial cells, with extension into the lumen 
and the adventitial spaces (З). As described in the 
Introduction, the resulting inflammatory reaction is 
characterized by early accumulation of PMNs in the vessels, 
maximal at 2-4 hours after injection of the antigen, in later 
stages followed by vessel wall damage, intravascular platelet 
aggregation with coagulation, and necrosis. 
Experimental acute serum sickness is induced by i.v. 
injection of one large dose of a heterologous protein (mostly 
purified bovine serum albumin, BSA) into a rabbit, or other 
animal. A generalized vasculitis develops during the period 
from day 7 to 15 after the injection (4, 5). The occurrence 
of the acute vascular lesions is closely related to the 
simultaneous presence of both antibody and antigen in the 
circulation, and by immunofluorescence antigen, antibody and 
complement can be demonstrated in the vessels (5,6). The 
histologic lesions are variable, but consist mainly of PMN 
infiltration and endothelial proliferation, together with 
signs of increased vascular permeability (5-7). 
In the model of experimental chronic serum sickness the 
antigen (BSA) is administered for several weeks in constant 
daily doses (θ). This leads, under certain circumstances, to 
the development of a chronic glomerular disease, clinically 
accompanied with proteinuria, and morphologically 
characterized by subepithelial deposits of immunoglobulins, 
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without apparent cellular reaction (8,9). The glomerular 
lesion resembles that of the Passive Heymann Nephritis. 
In the Passive Heymann Nephritis (PHN) heterologous 
antibodies, raised against autologous tubular antigens, are 
injected i.v. into a rat (10,11). This leads to the 
development of a glomerular lesion, that like that of chronic 
serum sickness, is characterized by epimembranous , i.e. 
subepithelial depositions of immunoglobulins in the glomerular 
capillaries, without morphological signs of cellular 
inflammation (12). Also in this model the glomerular 
pathology is accompanied with proteinuria. 
Another model of antibody mediated vasculitis is that of the 
Nephrotoxic Uephritis (NTH), induced by injection of 
heterologous antibody directed against structures of the 
glomerular basement membrane (13)· The morphology of the 
early glomerular lesion is that of an acute inflammation with 
accumulation of PMNs in the glomerular capillaries, resembling 
the vasculitis of the Arthus reaction (14,15). In the early, 
heterologous phase of the reaction binding of the antibodies 
to the glomerular basement membrane can be demonstrated 
ultrastructurally (13). In the second, autologous phase 
irregular deposits of electron dense material appear in the 
subendothelial region at the luminal side of the basement 
membrane. Both the heterologous and the autologous phase of 
the NTN are clinically accompanied with proteinuria. In the 
following discussions we will only refer to the early phase of 
the model, in which the heterologous antibody binds to the 
antigenic structures located in the basement membrane. With 
regard to its initiation by binding of antibody to structures 
that are fixed in the vessel wall the NTN shows a similarity 
to our model of AAR, in which an acute necrotizing vasculitis 
is induced by injection of specific antibody against antigenic 
determinants located on the vascular endothelium. 
The striking resemblance of clinical forms of immune 
vasculitis to experimental acute serum sickness and the 
finding that in serum sickness, as well as in vascular lesions 
of other forms of immune vasculitis, immune complexes could be 
demonstrated both in the circulation and as depositions in the 
vessel walls, have led to the general assumption that most, if 
not all, types of immune vasculitis were caused by the 
deposition of circulating immune complexes in the vessel walls 
(5,7). In view of this concept, the hyperacute rejection of 
skin grafts by iramunosu'ppressed mice, induced by intravenous 
injection of antibody that specifically binds to the 
endothelial cells of the graft, represents a model of immune 
vasculitis that can hardly be considered analogous to clinical 
immune complex disease. However, the concept that most types 
of immune vasculitis are caused by local "trapping" of 
preformed immune complexes has been seriously challenged 
recently, and there is accumulating evidence that local 
binding of immunoglobulins to fixed antigens plays a far more 
important role than has been previously assumed. Several 
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findings have made it necessary to modify the original concept 
of immune complex disease. In studies on the factors that 
determine the pathogenicity of circulating immune complexes it 
proved to be very difficult to induce experimental immune 
vasculitis by intravenous injection of preformed immune 
complexes (16). On the other hand, immune complexes could be 
demonstrated in the circulation of many patients without 
apparent immunovascular disease (16,17). Recent findings in 
models of immune vasculitis that formerly were thought to be 
prototypes of immune complex disease have also made this 
assumption questionable. For example, recent data suggest 
that both in the Passive Heymann Nephritis and in the chronic 
serum sickness the subepithe-lial deposits of immunoglobulins 
are not caused by local "trapping" of immune complexes, but 
are the result of binding of antibody to locally present 
intrinsic or planted antigens (18-20). The morphologic 
features of the glomerulopathy of the PUN and chronic serum 
sickness show a striking resemblance to those of clinical 
membranous nephropathy. Since also the occurrence of clinical 
membranous nephropathy could not be related to the presence of 
immune complexes in the circulation it is assumed that, 
analogous to the pathogenesis of PUN, the immune deposits in 
membranous nephropathy are the result of an in situ binding of 
antibody to fixed antigen (21). An indication that this may 
indeed be the case is the finding that DNA can bind in vitro 
to glomerular basement membrane and other collagenous 
structures (22), which could explain the occurrence of 
membranous neprhopathy in SLE, induced by binding of 
anti-DNA-antibodies. 
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In our opinion the above mentioned data, that suggests the 
occurrence of localized antigen-antibody reactions in 
experimental models and in clinical syndromes that previously 
were considered to be typical immune complex diseases, 
significantly increases the relevance of the model of AAR for 
the understanding of the pathogenesis of clinical vasculitis. 
It may be an important factor that in the AAR the antigen is 
located on the cell membrane of the vascular endothelium, 
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which means that in these circumstances the endothelial cells 
are not damaged as "innocent hystanders" of the inflammatory 
process, as is assumed in most of the above described models 
(25,26) but as the target cells of the direct attack of 
antibody. On the other hand, it is an obvious advantage of 
the model of AAR of skin grafts in mice that it enables us to 
define and manipulate the antigenic determinants, and thus to 
study the influence of antigenic structures on the development 
of vascular damage. The results of our experiments with AAR 
on skin allografts and xenografts in the mouse have shown that 
not only the occurrence of antibody-induced vasculitis, but 
also the morphology along which it develops and the degree in 
which effector systems such as complement are involved, are 
closely related to antigenic factors such as the number of 
antigenic targets and their accessibility for antibody in the 
circulation. Furthermore,' our study on the expression of la 
antigens in mouse allografts has shown that the presence of 
these antigenic structures is related to the immunologic 
status of the host, and can vary with time within the same 
animal. Apart from the significance of these findings for our 
understanding of the physiologic role of la antigens on 
endothelial cells, further studies in this model may help to 
solve the question whether antibodies against HLA-DR (the 
human counterpart of the murine la antigens) have destructive 
capacity in clinical transplantation. 
For the study of effector mechanisms the antibody induced 
vasculitis of AAR is clearly suitable, and it seems likely 
that insight in the pathogenic mechanisms of antibody-induced 
rejection can lead to a better understanding not only of 
clinical graft rejection, but also of other forms of clinical 
immunovascular disease, that show similarities in morphologic 
features. As mentioned before, classic candidates for 
effector roles in various models of immune vasculitis have 
been complement, PMNs, platelets, and the coagulation system. 
We will briefly discuss parallels between our findings in the 
AAR and those in the above mentioned other models of 
vasculitis. 
The role of complement. There are several ways in which the 
complement system can act as effector mechanism in 
antibody-mediated cell damage. The first way is that of 
direct complement induced cell lysis, after activation of the 
complement cascade by the binding of antibody to antigenic 
structures on the target cell, and subsequent membrane attack 
by terminal complement components. The second way in which 
complement can mediate cell damage after activation by an 
antigen-antibody reaction is by attracting PMNs, which on 
their turn cause tissue damage by release of lysosomal enzymes 
during the process of phagocytosis of the immune complexes. 
The chemotactic attraction of PMNs is mainly effected by the 
factor C5a, and, to a lesser degree, the C567 complex, formed 
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during activation (27-29). This indirect effector role of 
complement in cooperation with PMNs has traditionally been 
assumed to be the most important one in the induction of 
immune vasculitis. A third way in which complement can 
possibly play a role in effecting cell damage is by induction 
of antibody mediated cell lysis by platelets. This mechanism 
has been shown to be effective in vitro, in an experimental 
setting in which antibody coated erythrocytes were incubated 
with platelets in the presence of early complement factors 
(30). 
The role of complement in different models of immune 
vasculitis is not clear. The Arthus reaction and the early 
phase of the NTN are generally considered to be complement 
dependent and the main function of complement in these types 
of immune vasculitis is thought to be that of a 
chemoattractant for PMNs (15). However, in both these models 
it has been reported that very high doses of antibody can 
cause vessel wal .damage in the absence of both complement and 
PMNs (3,14). The arteritis of serum sickness has also been 
reported to be complement dependent (6) but neither depletion 
of complement nor that of neutrophils prevents the development 
of glomerular lesions (31 ,32). Another role for complement, 
not as chemoattractant but independently from PMN activity, 
has been suggested in PHN, since in this model C3 depletion 
inhibits the proteinuria, whereas PMN depletion does not 
(33,34). This is consistent with the absence of PMN 
accumulation in the glomerular capillaries in this lesion. 
Therefore, complement must have another function here than 
that of producer of chemotactic factors. There is evidence 
that activation of the complete lytic pathway is required for 
the occurrence of the proteinuric effect (33,34). It has been 
reported that the terminal C5-C9 membrane attack complex of 
complement can also damage non-cellular membranous structures 
(35). Still, how complement effects its mediation in the 
PMN-independent induction of damage to the glomerular 
capillaries in PHN remains so far unclear. 
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the endothelium are relatively sparse, the AAR is clearly 
dependent on the availability of an effective complement 
system. In this combination of donor and recipient the weakly 
acting endogenous complement system of the mouse is not 
sufficient to induce AAR after administration of specific 
antibody, not even when the injected dose is very high (36). 
In these mouse skin allografts AAR can only be elicited when 
together with the antibody a more efficient heterologous 
complement is injected, such as guinea pig complement, human 
complement, or, the most efficient one, rabbit complement 
(37,38). In the xenograft model, in which more abundant 
antigenic targets are available for binding with the antibody, 
the murine complement is efficient enough for induction of AAR 
(39), and in this combination AAR can even be induced in the 
absence of complement, provided that the dose of antibody is 
substantially raised (40,41). The finding that neither the 
Shwartzman-like nor the Arthus-like type of AAR was prevented 
or inhibited by PMN depletion made it clear that in the AAR 
activated complement does not act via attraction of P^Ns, and 
consequently we now favor the opinion that in the presence of 
complement the initial damage to the endothelial cells of the 
graft is that of a direct antibody-mediated cell lysis, caused 
by activation of the complement cascade. In this respect the 
AAR is different from the other models of immune vasculitis m 
which the antigen is not located on the endothelial cell 
membrane, but either deposited or fixed onto vessel wall 
structures, or present as a soluble factor m blood or 
interstitial fluid. 
In these cases complement-dependent tissue damage must be 
effected either by secondary inflammatory mechanisms, or, as 
mentioned above, by complement-induced damage to non-cellular 
membranous structures. 
The way m which in the AAR vessel wall damage is induced in 
the absence of complement remains so far unclear. Our initial 
hypothesis that m complement depleted or complement deficient 
recipients PMMs, under these circumstances attracted by other 
chemotactic factors than complement components, were 
responsible for the initial vessel wall damage, was no longer 
tenable after our subsequent finding that PMN depletion did 
not prevent the AAR in the absence of complement. It could be 
argued that very low, unmeasurable traces of complement are 
still present locally in Cobra Venom Factor treated animals, 
and that these minimal amounts of complement could be 
sufficient to induce endothelial cell lysis in the presence of 
the very large doses of antibody, that are necessary in these 
circumstances to induce AAP. However, in congenitally C5 
deficient mice the complement cascade cannot be fully 
activated, and in these circumstances other effector systems 
that are either complement-independent, or that only require 
minimal amounts of early complement components, must be 
operative. 
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The role of platelets. In general, platelet aggregation and 
intravascular coagulation are not characteristic features of 
the early phases of iramunovascular diseases, including those 
of serum sickness, NTN, and PHN, and there is no indication 
that platelets play an important role in these processes. In 
the Arthus reaction platelet aggregation and intravascular 
coagulation occur in the later stages of the process, and, 
although the obstruction of the circulation may increase the 
tissue damage, it has been shown that depletion of platelets 
or treatment with heparin does not prevent the reaction (3). 
In the AAR, platelet aggregation and intravascular coagulation 
can be the first and most impressive sign of vascular 
destruction, thus causing a resemblance of the vasculitis to 
that of the generalized Shwartzman reaction. Assuming that in 
this type of AAR the damaging potential of antibody and 
complement is sufficient to cause immediate endothelial cell 
lysis, the early platelet aggregation, caused by denuding of 
the vascular surface, could be an important secondary pathway 
that augments the resulting tissue necrosis. If, however, 
contrary to our hypothesis, the inital event in the vasculitis 
of AAR is not a direct complement induced endothelial cell 
destruction, platelets could possibly play a role as 
initiators of the inflammatory process by means of platelet 
induced lysis of antibody coated cells, dependent on the 
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presence of early complement factors (30). We mentioned this 
mechanism as one of the ways in which complement can mediate 
cell damage. There is some evidence that this lytic effect of 
platelets may also be effective in vivo (30). 
Preliminary results of experiments in which 
platelet depleted and heparin treated re 
that these treatments do not prevent the oc 
complement normal mice, neither the Arthus 
type. Moreover, platelet depletion did 
Shwartzman-like type of AAR into an Arthus-
expected. In these mice we observed, after 
doses of antibody, rapid rejection of all 
that in control groups with normal 
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an Arthus-like one. Conversely, supplementary administration 
of rabbit complement caused a violent Shwartman-like graft 
destruction after injection of low doses of antibody, that in 
complement normal mice gave a more slowly developing 
Arthus-like reaction. ¥e conclude that not only the amount of 
antibody but also the availability of complement can be the 
decisive factor that determines whether or not acute 
antibody-mediated rejection will occur and along which 
histological pattern the vasculitis will take place. When 
large doses of antibody are injected, however, complement is 
not an absolute requirement for the occurrence of 
antibody-mediated graft destruction. 
The histologic resemblance of the vasculitis of the AAR 
occurring either after injection of low doses of antibody or 
in the absence of complement, to the experimental Arthus 
reaction suggested an essential role for polymorphonuclear 
granulocytes in the initiation of the vessel wall damage. On 
the other hand the morphology of the AAR which occurred after 
injection of high doses of antibody or in the presence of 
abundant amounts of highly effective complement, and which 
developed along a Shwartzman-like type of vasculitis, 
suggested that PMNs did not play an important role in the 
early phases of the process. 
Therefore, the role of granulocytes in either type of 
vasculitis was tested by 'inducing AAR in recipients depleted 
of PMNs. Since conventional methods to induce granulocyte 
depletion, such as treatment with Nitrogen Mustard or 
anti-granulocyte serum, proved to be insufficient to effect a 
stable PMN depletion in mice for several days, and were 
accompanied by considerable toxic side effects, we induced PMN 
depletion by Total Body Irradiation (TBI). 
This irradiation was given in a single dose of 6.0 Gy 
(600 rad), at a dose rate of 0.20 Gy min" . To prevent 
infection, the mice were kept in a laminar flow unit from two 
days before until 3 weeks after the irradiation, under an 
aseptic regimen and protective antibiotic treatment. The TBI 
of 6.0 Gy reduced the number of PMNs in the peripheral 
circulation of the mice to levels below 150/ul from 3 to 10 
days after the irradiation, without causing significant 
changes in complement levels. The number of lymphocytes 
dropped simultaneously with that of granulocytes, but platelet 
counts remained above 60$ of normal values in the first 7 days 
after the irradiation. Furthermore, the TBI, under the 
aseptic regimen, did not visibly impair the general condition 
of the mice. 
To investigate the effect of PMN depletion on the AAR of rat 
skin xenografts, mice received a TBI of 6.0 Gy on day 4 after 
transplantation, and mouse anti-rat globulin was injected 
intravenously on day 8 after transplantation. 
Our results show that neutrophil depletion did not prevent the 
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cells is variable and depends on the immune status of the 
recipient. These findings suggest that the vascular 
endothelium can act as target in la-incompatitle skin 
allograft rejection. 
Study of the mechanisms involved 
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SAMENVATTING 
HYPERACUTE ANTILICHAAK-AFHANKELIJKE TRANSPLANTAAT-AFSTOTING 
ALS MODEL VOOR IMMUUNVASCULITIS 
De morfologie van de vasculitis van de hyperacute 
antilichaam-afhankelijke transplantaat-rejectie (AAR), en de 
rol van mediatoren in dit proces, werd bestudeerd in een model 
waarin PVG/c rattehuid werd getransplanteerd op de flank van 
C57B1/10 muizen, die, ter voorkoming van cellulaire afstoting, 
behandeld werden met anti-lymfосуten serum. Op dag 7 of 8 na 
transplantatie werd hyperacute afstoting opgewekt door 
intraveneuze toediening van muis-anti-rat serum. 
Bij histologisch onderzoek bleek dat het patroon waarin de 
vasculitis van de acute afstoting zich ontwikkelde afhankelijk 
was van de dosis toegediend antiserum: wanneer lage doses 
werden ingespoten zagen we een afs totingsprocea dat 
morfologisch gekenmerkt werd door een vroeg optredende 
accumulatie van granulocyten in de transplantaatvaten, in 
latere stadia gevolgd door het optreden van 
vaatwandbeschadiging, intravasale stolling en necrose. Dit 
type vaatreactie lijkt sterk op dat van de experimentele 
Arthus-reactie. Na het toedienen van hoge doses antiserum 
trad een ander type vasculitis op, dat vooral gekenmerkt werd 
door een vrijwel onmiddellijk optredende intravasculaire 
plaatjes-aggregatie en stolling, een beeld dat ook gezien 
wordt bij de experimentele gegeneraliseerde 
Shwartzman-reactie. Na het toedienen van tussenliggende doses 
antiserum zagen we mengvormen optreden van beide genoemde 
typen van vasculitis. 
De bovengenoemde patronen van vaatreactie zijn ook beschreven 
bij hyperacute antilichaam-afhankelijke transplantaat-re jee tie 
in andere diermodellen, en in klinische afs to tings-reacties. 
De opvallende morfologische verschillen tussen 
vasculitisvormen van het Arthus-type en van het 
Shwartzman-type, en de verschillende rol die granulocyten en 
plaatjes lijken te spelen т.п. in de vroege fase van de 
reactie, hebben geleid tot tegenstrijdige theorieën over de 
rol van mediatoren in de Pathogenese van de 
antilichaam-afhankelijk afstoting. Onze resultaten tonen aan 
dat de Arthus-achtige en de Shwartzman-achtige vormen van 
vasculitis niet beschouwd moeten worden als twee 
pathogenetisch verschillende reacties, maar als onderdelen van 
één morfologisch spectrum van vaatwandbeschadiging. 
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Hierbij kan de hoeveelheid toegediend antiserum de factor zijn 
die bepaalt welk type reactie zal optreden. 
De rol van complement in de AAR werd getest door hyperacute 
afstoting van rattehuidtransplanta ten op te wekken bij muizen 
waarin de lytische aktiviteit van complement werd 
uitgeschakeld d.m.v. behandeling met Cobra Venom Factor. Het 
bleek dat bij ontbreken van complement-aktivi teit hyperacute 
afstoting slechts kon worden opgewekt wanneer hoge doses 
antiserum werden toegediend. Bovendien bleek dat het 
morfologisch patroon van de vasculitis die optrad na inspuiten 
van deze hoge doses, door het ontbreken van complement, 
veranderde van een fulminant verlopend Shwartzman-type in een 
minder snel verlopend Arthu^-type. Omgekeerd konden we d.m.v. 
extra toediening van efficient heteroloog konijne-complement 
een afstoting volgens een Arthus-patroon, zoals optreedt na 
toediening van lage doses antistoffen, doen veranderen in een 
reactie volgens een heftig verlopend Shwartzman-patroon. Uit 
deze experimenten bleek dat zowel het optreden van de AAR, als 
het patroon waarlangs de vaatontsteking verloopt, niet alleen 
wordt bepaald door de dosis toegediend antiserum, maar ook 
door de mate waarin complement beschikbaar is. Hiermee worden 
ook de resultaten van eerdere experimenten bevestigd, waaruit 
bleek dat het complement-systeem weliswaar funktioneert als 
een belangrijk amplificatie-mechanisme in het ontstaan van 
vaatwand-destruktie, maar dat het niet onmisbaar is voor het 
optreden van AAR. 
Het feit dat AAR in sommige gevallen verloopt volgens een 
vasculitispatroon dat sterk lijkt op dat van de 
Arthus-reaktie, en in andere gevallen volgens een beeld van 
acute vaatwanddestruktie, zoals gezien wordt bij de 
gegeneraliseerde Shwartzman-reactie, heeft geleid tot 
verschillende, tegenstrijdige hypothesen over de Pathogenese 
van de vaatwand-beschadiging, waarin enerzijds aan 
granulocyten, anderzijds aan plaatjes en het stollingssysteem 
een belangrijke rol werd toegeschreven bij de induktie van de 
prinaire vaatwand-beschadiging. Doordat we in ons model van 
hyperacute afstoting van xeno-transplanta ten bij de muis zowel 
een Arthus- als een Shwartzman-type van vasculitis konden 
opwekken, was het mogelijk om de rol van mediatoren te testen 
in beide vormen van vasculitis afzonderlijk. Voor het 
bestuderen van de rol van granulocyten testten we het effect 
van granulocyten-depletie op het ontstaan van AAR. 
Aanvankelijk werd getracht granulocyten-depletie bij de muizen 
op te wekken met vaak gebruikte methoden zoals behandeling met 
stikstofmosterd of net anti-granulocyten serum. Deze 
behandelingen leidden echter niet tot een reproduceerbare 
granulocyten-depletie, waarbij het aantal segmentkernigen in 
de circulatie gedurende enkele dagen beneden het niveau van 
150/μ1 gehouden kon worden. We trachtten daarom dit effect te 
bereiken door totale lichaamsbestraling. Deze werd gegeven 
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Op basis van bovengenoemde experimenten hebben we onze 
oorspronkelijke veronderstelling dat granulooyten een 
belangrijke rol spelen in het ontstaan van de primaire 
vaatwandbeschadiging in de AAR, met name in die van het 
Arthus-type, moeten herzien. De resultaten van onze 
experimenten ondersteunen de hypothese, dat de primaire 
vaatwand-beschadiging in de AAR ontstaat door een direkte 
complement-afhankelijke lysis van de endotheel cellen, 
veroorzaakt door aktivatie van complement t.g.v. de binding 
van antilichaam aan antigenen, die gelokaliseerd zijn op de 
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celraembraan. Aan de andere kant verklaart deze hypothese niet 
het optreden van AAR hij complement-deficiënte of met Cobra 
Venom Factor behandelde ontvangers. 
Het feit dat het endotheel van de transplantaatvaten fungeert 
als doelwit voor zowel de cellulaire als de 
antilichaam-afhankelijke afstotingsreactie kan verklaard 
worden door de algemene aanwezigheid van Klasse I antigenen op 
alle cellen. Klasse II antigenen zijn echter niet op alle 
cellen aanwezig, en waren tot dusverre niet aangetoond op 
endotheel van de muis. Omdat in muizen toch afstoting van 
allo-transplantaten optreedt over Ia-verschillen werd 
aangenomen, dat deze afstoting werd geïnduceerd door 
la-antigeen dragende Langerhans cellen aanwezig in het 
transplantaat. In een experimenteel model waarin we trachtten 
de la-antigenen in het transplantaat aan te tonen d.m.v. het 
in vivo inspuiten van radioactief gelabelde monoclonale 
anti-Ia antilichamen bij dragers van Ia-incompatibele 
transplantaten, vonden we, dat onder bepaalde omstandigheden 
la-antigeen ook kon worden aangetoond op het 
transplantaat-endotheel. De expressie van deze antigenen 
bleek nauw samen te hangen met de immuunstatus van de 
ontvanger. Bij muizen die behandeld waren met antilymfocyten 
serum, of Cyclosporine A, of waarbij een 
congenitale-immuundeficientie bestond gecombineerd met het 
congenitaal ontbreken van de thymus, was geen expressie van 
la-antigenen op het endotheel aantoonbaar. Bij muizen echter, 
waarbij de immuun-reacti viteit intakt was, kon met 
immunofluorescentie en autoradiografie la-antigeen worden 
aangetoond op het endotheel van de transplantaten. 
Kwantitatieve meting van de binding van gelabelde 
anti-la-antistof werd verricht door het tellen van de 
radioaktiviteit in de transplantaten op verschillende 
tijdstippen na het inspuiten van het antiserum. De resultaten 
van deze experimenten suggereren dat het vaatwand-endotheel, 
als drager van la-antigeen, kan fungeren als rechtstreeks 
doelwit in de afstoting over Ia-verschillen. 
Het bestuderen van de pathogenetische mechanismen in de 
vasculitis van de acute antilichaam-afhankelijke afstoting is 
niet alleen van belang om een beter inzicht te krijgen in de 
processen die leiden tot acute of chronische 
antilichaam-afhankelijke transplantaatbeschadiging, maar kan 
ook het inzicht vergroten in andere vormen van vasculitis die 
veroorzaakt worden door antilichamen. Hoewel tot voor kort 
algemeen werd aangenomen, dat de meeste vormen van klinische 
en experimentele immunologisch geïnduceerde 
vaatwand-ontstekingen veroorzaakt werden door het neerslaan of 
gevangen worden van immuuncomplexen in de vaatwand, is op 
grond van recente studies deze veronderstelling in twijfel 
getrokken. Het is gebleken dat in sommige vormen van 
experimentele immuun-vasculitis, die vroeger beschouwd werden 
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vriendschappelijke hulp van de medewerkers van het Centraal 
Dierenlaboratorium. Met name Jan Koedam en Lia van de 
Vorle-Houben ben ik erkentelijk voor hun hulp en advies bij 
het huisvesten van de bestraalde muizen. Ook de medewerkers 
van de experimentele boerderij in Overasselt wil ik graag mijn 
dank betuigen. De medewerkers van de Afdeling Radiotherapie 
wil ik bedanken voor de soepelheid waarmee tijd en ruimte werd 
vrijgemaakt voor onze muizen, en voor de zorgvuldigheid en 
efficiëntie waarmee de bestraling werd uitgevoerd. Ook ben ik 
blij hier mijn dank te kunnen betuigen aan de medewerkers van 
de Afdeling Medische Fotografie, die op vakkundige wijze de 
foto's verzorgd hebben, en die altijd bereid zijn tot het 
geven van advies. Op gelijke wijze ben ik dank verschuldigd 
aan de medewerkers van de Afdeling Medische Illustratie. De 
medewerkers van het laboratorium Kindergeneeskunde stelden hun 
apparatuur ter beschikking voor het tellen van bloedcellen en 
-plaatjes. De heer E. de Graaff en medewerkers van de 
Centrale Bibliotheek, Gerry Hermkens en Anita de Vries hebben 
geholpen bij het verzamelen van de literatuur. Tenslotte wil 
ik Erna Franssen-Kokke, Anita de Vries en Janny van Rennes 
bedanken voor het typen van de artikelen, en Janny van Rennes 
nog eens speciaal voor het persklaar maken van het manuscript. 
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STELLINGEN 
I 
Uit de opvallende intravasculaire aanwezigheid van granulocyten 
in de eerste fase van acute antilichaam-afhankelijke rejectie is 
ten onrechte geconcludeerd dat deze cellen een essentiële rol 
spelen in het initiëren van de vaatwandbeschadiging. 
II 
Totale lichaamsbestraling is tot dusverre de meest geschikte 
methode om granulocytendepletie op te wekken bij de muis. 
III 
Bij klinische immuunvasculitis speelt de reactie van antilichamen 
met in de vaatwand gefixeerde antigenen naar alle waarschijnlijkheid 
een veel belangrijker rol dan tot dusverre verondersteld werd. 
IV 
Hoewel het prognostisch belang van de morfologische typering van 
de ziekte van Hodgkin door de aanzienlijk gestegen overlevings -
kansen van alle typen duidelijk is afgenomen, moet het gebruik van 
deze typering door pathologen, met in acht nemen van strikte criteria, 
gehandhaafd blijven om de huidige goede diagnostische accuratesse 
bij het stellen van de primaire diagnose niet verloren te doen gaan. 
V 
Het histologisch beeld van Hairy Cell leukemie in de milt kan, 
wanneer het karakteristiek en volledig is, als pathognomonisch 
voor deze ziekte beschouwd worden. 
VI 
Voor optimale hematologische beoordeling van in plastic ingebedde 
cristabiopten is het noodzakelijk dat de patholoog zijn bevindingen 
kan correleren met die in het uitstrijkpreparaat. 
VII 
Wanneer bij een patient met een testistumor de serumwaarden van 
β - choriogonadocrcpine en α - foetoproteine verhoogd zijn moet de 
tumor als een niet-seminomateuze testistumor behandeld worden, ook 
wanneer histologisch alleen een seminomateuze component kan 
worden aangetoond. 
Vili 
De monoclonale antistof WTI is niet alleen een veelbelovend 
immunosuppressivum, maar is ook een belangrijke aanwinst als 
Τ-cel marker in de diagnostiek van de acute lymfatische leukemie 
en het lymfoblastair lymfoom. 
IX 
Hoewel phase - contrast optiek de vormveranderingen van erythrocyten 
in de urine bij een glomerulaire hématurie het fraaist zichtbaar 
maakt, voldoet microscopie met een normale belichting en in lage 
stand geplaatste condensor uitstekend voor de routine - diagnostiek. 
X 
De ontwikkeling van de wetenschap heeft voldoende aangetoond dat 
"maatschappelijke relevantie" als selectie - criterium bij de 
beoordeling van wetenschappelijk onderzoek onbruikbaar is. 
XI 
Wanneer men de som van de frekwenties van rectumcarcinoom en 
prostaatcarcinoom bij de man vergelijkt met de frekwentie van 
mammacarcinoom of cervixcarcinoom bij de vrouw is het verwonderlijk 
dat er in het afgelopen decennium geen voorstellen zijn gedaan om 
alle mannen boven 50 jaar op te roepen om zich naar een in hun buurt 
gereedstaande bus te begeven en zich daar, tegen geringe vergoeding, 
door speciaal daarvoor opgeleide paramedische krachten rectaal te 
laten toucheren. 
XII 
Het irreversibel mislukken van een Sauce Béarnaise kan grotendeels 
voorkomen worden door de zuurgraad van de waterige vloeistof, die 
de basis vormt van de emulsie, zo laag mogelijk te kiezen. 
D.M.Small en M.Bernbtein. DocLor in the Kitchen: Experiments on Sauce Béarnaise. 
N Engl J Med 1979, 300: 801-80,». 
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